<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 201905//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.2?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Molecules</journal-id><journal-id journal-id-type="iso-abbrev">Molecules</journal-id><journal-id journal-id-type="publisher-id">molecules</journal-id><journal-title-group><journal-title>Molecules</journal-title></journal-title-group><issn pub-type="epub">1420-3049</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">8073654</article-id><article-id pub-id-type="doi">10.3390/molecules26082377</article-id><article-id pub-id-type="publisher-id">molecules-26-02377</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Phytochemicals and Bioactivities of <italic>Zingiber cassumunar</italic> Roxb</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-7824-4441</contrib-id><name><surname>Han</surname><given-names>Ah-Reum</given-names></name><xref ref-type="aff" rid="af1-molecules-26-02377">1</xref></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Hyunyoung</given-names></name><xref ref-type="aff" rid="af2-molecules-26-02377">2</xref></contrib><contrib contrib-type="author"><name><surname>Piao</surname><given-names>Donglan</given-names></name><xref ref-type="aff" rid="af2-molecules-26-02377">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3876-4201</contrib-id><name><surname>Jung</surname><given-names>Chan-Hun</given-names></name><xref ref-type="aff" rid="af3-molecules-26-02377">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1950-2348</contrib-id><name><surname>Seo</surname><given-names>Eun Kyoung</given-names></name><xref ref-type="aff" rid="af2-molecules-26-02377">2</xref><xref rid="c1-molecules-26-02377" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>S&#x000fc;lsen</surname><given-names>Valeria Patricia</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-molecules-26-02377"><label>1</label>Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute (KAERI), Jeongeup-si, Jeollabuk-do 56212, Korea; <email>arhan@kaeri.re.kr</email></aff><aff id="af2-molecules-26-02377"><label>2</label>College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Korea; <email>fanet0106@naver.com</email> (H.K.); <email>parkdl@ehwain.net</email> (D.P.)</aff><aff id="af3-molecules-26-02377"><label>3</label>Jeonju AgroBio-Materials Institute, Jeonju-si, Jeollabuk-do 54810, Korea; <email>biohun@gmail.com</email></aff><author-notes><corresp id="c1-molecules-26-02377"><label>*</label>Correspondence: <email>yuny@ewha.ac.kr</email>; Tel.: +82-2-3277-3047</corresp></author-notes><pub-date pub-type="epub"><day>19</day><month>4</month><year>2021</year></pub-date><pub-date pub-type="collection"><month>4</month><year>2021</year></pub-date><volume>26</volume><issue>8</issue><elocation-id>2377</elocation-id><history><date date-type="received"><day>24</day><month>3</month><year>2021</year></date><date date-type="accepted"><day>16</day><month>4</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; 2021 by the authors.</copyright-statement><copyright-year>2021</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p><italic>Zingiber cassumunar</italic> Roxb. (Zingiberaceae), is an important medicinal plant known as &#x0201c;Plai (Phlai)&#x0201d; in Thailand, &#x0201c;Bangle&#x0201d; in Indonesia, and &#x0201c;Bulei&#x0201d; in China. Traditionally, this plant has been used to treat inflammation, pain, and respiratory problems. The rhizomes are the primary part of the plant that has been used for medicinal purposes due to their constituents with therapeutic properties, including phenylbutenoids, curcuminoids, and essential oils. Since the 1970s, many studies have been conducted on the phytochemicals and bioactivities of <italic>Z. cassumunar</italic> to establish fundamental scientific evidence that supports its use in traditional medicine. The accumulated biological studies on the extracts, solvent fractions, and constituents of <italic>Z. cassumunar</italic> have described their diverse medicinal properties, including antioxidant, anti-inflammatory, anticancer, neuroprotective/neurotrophic, cosmeceutical, and antifungal/antimicrobial bioactivities. In this review, we summarize information on the phytochemicals of <italic>Z. cassumunar</italic> and the bioactivities of its extracts and constituents.</p></abstract><kwd-group><kwd><italic>Zingiber cassumunar</italic></kwd><kwd>Zingiberaceae</kwd><kwd>phenylbutenoid</kwd><kwd>curcuminoid</kwd><kwd>essential oil</kwd><kwd>antioxidant</kwd><kwd>anti-inflammation</kwd><kwd>anticancer</kwd><kwd>neurotrophic activity</kwd><kwd>cosmeceutical property</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-molecules-26-02377"><title>1. Introduction</title><p><italic>Zingiber cassumunar</italic> Roxb. belongs to the family Zingiberaceae and is an herbaceous and perennial plant consisting of an underground part consisting of rhizomes (<xref ref-type="fig" rid="molecules-26-02377-f001">Figure 1</xref>). In Thailand, Indonesia, and other Asian countries, <italic>Z. cassumunar</italic> has traditionally been used as a medicinal plant in folk remedies for the treatment of various illness, such as inflammation, including arthritis, rheumatisms, sprains, respiratory problems such as asthma and cough, and pain caused by musculoskeletal, menstrual, or gastrointestinal disorders [<xref rid="B1-molecules-26-02377" ref-type="bibr">1</xref>]. Several types of compounds in <italic>Z. cassumunar</italic> have been identified such as phenylbutenoids, curcuminoids, sesquiterpenoids, benzaldehydes, quinones, and essential oils containing monoterpenoids. Phenylbutenoids are characteristic compounds of this plant and have been isolated using various isolation technics [<xref rid="B2-molecules-26-02377" ref-type="bibr">2</xref>,<xref rid="B3-molecules-26-02377" ref-type="bibr">3</xref>,<xref rid="B4-molecules-26-02377" ref-type="bibr">4</xref>,<xref rid="B5-molecules-26-02377" ref-type="bibr">5</xref>,<xref rid="B6-molecules-26-02377" ref-type="bibr">6</xref>,<xref rid="B7-molecules-26-02377" ref-type="bibr">7</xref>,<xref rid="B8-molecules-26-02377" ref-type="bibr">8</xref>,<xref rid="B9-molecules-26-02377" ref-type="bibr">9</xref>,<xref rid="B10-molecules-26-02377" ref-type="bibr">10</xref>,<xref rid="B11-molecules-26-02377" ref-type="bibr">11</xref>,<xref rid="B12-molecules-26-02377" ref-type="bibr">12</xref>,<xref rid="B13-molecules-26-02377" ref-type="bibr">13</xref>,<xref rid="B14-molecules-26-02377" ref-type="bibr">14</xref>], including silica gel or reverse phase column chromatography [<xref rid="B2-molecules-26-02377" ref-type="bibr">2</xref>,<xref rid="B3-molecules-26-02377" ref-type="bibr">3</xref>,<xref rid="B4-molecules-26-02377" ref-type="bibr">4</xref>,<xref rid="B5-molecules-26-02377" ref-type="bibr">5</xref>,<xref rid="B6-molecules-26-02377" ref-type="bibr">6</xref>,<xref rid="B7-molecules-26-02377" ref-type="bibr">7</xref>,<xref rid="B8-molecules-26-02377" ref-type="bibr">8</xref>,<xref rid="B9-molecules-26-02377" ref-type="bibr">9</xref>,<xref rid="B10-molecules-26-02377" ref-type="bibr">10</xref>], recrystallization [<xref rid="B3-molecules-26-02377" ref-type="bibr">3</xref>,<xref rid="B4-molecules-26-02377" ref-type="bibr">4</xref>], preparative thin-layer chromatography [<xref rid="B6-molecules-26-02377" ref-type="bibr">6</xref>], countercurrent chromatography [<xref rid="B11-molecules-26-02377" ref-type="bibr">11</xref>,<xref rid="B12-molecules-26-02377" ref-type="bibr">12</xref>], and preparative high-performance liquid chromatography [<xref rid="B10-molecules-26-02377" ref-type="bibr">10</xref>,<xref rid="B13-molecules-26-02377" ref-type="bibr">13</xref>,<xref rid="B14-molecules-26-02377" ref-type="bibr">14</xref>]. Other constituents include curcuminoids, including a high content of curcumin as a yellow pigment in the rhizome [<xref rid="B13-molecules-26-02377" ref-type="bibr">13</xref>,<xref rid="B14-molecules-26-02377" ref-type="bibr">14</xref>,<xref rid="B15-molecules-26-02377" ref-type="bibr">15</xref>,<xref rid="B16-molecules-26-02377" ref-type="bibr">16</xref>,<xref rid="B17-molecules-26-02377" ref-type="bibr">17</xref>], two quinones [<xref rid="B3-molecules-26-02377" ref-type="bibr">3</xref>,<xref rid="B4-molecules-26-02377" ref-type="bibr">4</xref>,<xref rid="B18-molecules-26-02377" ref-type="bibr">18</xref>], phenolic compounds [<xref rid="B13-molecules-26-02377" ref-type="bibr">13</xref>,<xref rid="B17-molecules-26-02377" ref-type="bibr">17</xref>], and sesquiterpenoids such as (&#x02212;)-&#x003b2;-sesquiphellandrene and zerumbone [<xref rid="B12-molecules-26-02377" ref-type="bibr">12</xref>,<xref rid="B19-molecules-26-02377" ref-type="bibr">19</xref>,<xref rid="B20-molecules-26-02377" ref-type="bibr">20</xref>,<xref rid="B21-molecules-26-02377" ref-type="bibr">21</xref>]. The essential oils included sabinene and terpinen-4-ol as major volatile terpenes [<xref rid="B22-molecules-26-02377" ref-type="bibr">22</xref>,<xref rid="B23-molecules-26-02377" ref-type="bibr">23</xref>,<xref rid="B24-molecules-26-02377" ref-type="bibr">24</xref>,<xref rid="B25-molecules-26-02377" ref-type="bibr">25</xref>]. The extracts and constituents of <italic>Z. cassumunar</italic> have diverse bioactivities, including antioxidant [<xref rid="B21-molecules-26-02377" ref-type="bibr">21</xref>,<xref rid="B26-molecules-26-02377" ref-type="bibr">26</xref>,<xref rid="B27-molecules-26-02377" ref-type="bibr">27</xref>,<xref rid="B28-molecules-26-02377" ref-type="bibr">28</xref>], anti-inflammatory [<xref rid="B7-molecules-26-02377" ref-type="bibr">7</xref>,<xref rid="B9-molecules-26-02377" ref-type="bibr">9</xref>,<xref rid="B12-molecules-26-02377" ref-type="bibr">12</xref>,<xref rid="B19-molecules-26-02377" ref-type="bibr">19</xref>,<xref rid="B23-molecules-26-02377" ref-type="bibr">23</xref>,<xref rid="B29-molecules-26-02377" ref-type="bibr">29</xref>,<xref rid="B30-molecules-26-02377" ref-type="bibr">30</xref>,<xref rid="B31-molecules-26-02377" ref-type="bibr">31</xref>,<xref rid="B32-molecules-26-02377" ref-type="bibr">32</xref>,<xref rid="B33-molecules-26-02377" ref-type="bibr">33</xref>,<xref rid="B34-molecules-26-02377" ref-type="bibr">34</xref>,<xref rid="B35-molecules-26-02377" ref-type="bibr">35</xref>,<xref rid="B36-molecules-26-02377" ref-type="bibr">36</xref>,<xref rid="B37-molecules-26-02377" ref-type="bibr">37</xref>,<xref rid="B38-molecules-26-02377" ref-type="bibr">38</xref>,<xref rid="B39-molecules-26-02377" ref-type="bibr">39</xref>], anticancer [<xref rid="B8-molecules-26-02377" ref-type="bibr">8</xref>,<xref rid="B13-molecules-26-02377" ref-type="bibr">13</xref>,<xref rid="B15-molecules-26-02377" ref-type="bibr">15</xref>,<xref rid="B40-molecules-26-02377" ref-type="bibr">40</xref>,<xref rid="B41-molecules-26-02377" ref-type="bibr">41</xref>,<xref rid="B42-molecules-26-02377" ref-type="bibr">42</xref>,<xref rid="B43-molecules-26-02377" ref-type="bibr">43</xref>,<xref rid="B44-molecules-26-02377" ref-type="bibr">44</xref>,<xref rid="B45-molecules-26-02377" ref-type="bibr">45</xref>,<xref rid="B46-molecules-26-02377" ref-type="bibr">46</xref>,<xref rid="B47-molecules-26-02377" ref-type="bibr">47</xref>,<xref rid="B48-molecules-26-02377" ref-type="bibr">48</xref>], neuroprotective/neurotrophic [<xref rid="B14-molecules-26-02377" ref-type="bibr">14</xref>,<xref rid="B19-molecules-26-02377" ref-type="bibr">19</xref>,<xref rid="B20-molecules-26-02377" ref-type="bibr">20</xref>], cosmeceutical [<xref rid="B17-molecules-26-02377" ref-type="bibr">17</xref>,<xref rid="B21-molecules-26-02377" ref-type="bibr">21</xref>], and antifungal/antibacterial [<xref rid="B22-molecules-26-02377" ref-type="bibr">22</xref>,<xref rid="B23-molecules-26-02377" ref-type="bibr">23</xref>,<xref rid="B24-molecules-26-02377" ref-type="bibr">24</xref>] activities. Although there has been a review of the clinical effects of various formulations using Plai (<italic>Z. cassumunar</italic>) on were pain relief, acne treatment, and antihistamine [<xref rid="B1-molecules-26-02377" ref-type="bibr">1</xref>], there has been no previous report summarizing the accumulated studies in the literature on the phytochemicals and in vitro and in vivo biological properties of <italic>Z. cassumunar</italic>, including our previous studies that have contributed to discovering the chemical diversity and biological activities of this plant [<xref rid="B8-molecules-26-02377" ref-type="bibr">8</xref>,<xref rid="B9-molecules-26-02377" ref-type="bibr">9</xref>,<xref rid="B15-molecules-26-02377" ref-type="bibr">15</xref>,<xref rid="B21-molecules-26-02377" ref-type="bibr">21</xref>,<xref rid="B25-molecules-26-02377" ref-type="bibr">25</xref>,<xref rid="B26-molecules-26-02377" ref-type="bibr">26</xref>,<xref rid="B27-molecules-26-02377" ref-type="bibr">27</xref>,<xref rid="B28-molecules-26-02377" ref-type="bibr">28</xref>,<xref rid="B29-molecules-26-02377" ref-type="bibr">29</xref>,<xref rid="B30-molecules-26-02377" ref-type="bibr">30</xref>,<xref rid="B31-molecules-26-02377" ref-type="bibr">31</xref>,<xref rid="B32-molecules-26-02377" ref-type="bibr">32</xref>].</p></sec><sec id="sec2-molecules-26-02377"><title>2. Phytochemicals from <italic>Z. cassumunar</italic></title><sec id="sec2dot1-molecules-26-02377"><title>2.1. Phenylbutenoids</title><p>Phenylbutenoids have been isolated mainly from <italic>Z. cassumunar</italic> [<xref rid="B2-molecules-26-02377" ref-type="bibr">2</xref>,<xref rid="B3-molecules-26-02377" ref-type="bibr">3</xref>,<xref rid="B4-molecules-26-02377" ref-type="bibr">4</xref>,<xref rid="B5-molecules-26-02377" ref-type="bibr">5</xref>,<xref rid="B6-molecules-26-02377" ref-type="bibr">6</xref>,<xref rid="B7-molecules-26-02377" ref-type="bibr">7</xref>,<xref rid="B8-molecules-26-02377" ref-type="bibr">8</xref>,<xref rid="B9-molecules-26-02377" ref-type="bibr">9</xref>,<xref rid="B10-molecules-26-02377" ref-type="bibr">10</xref>,<xref rid="B11-molecules-26-02377" ref-type="bibr">11</xref>,<xref rid="B12-molecules-26-02377" ref-type="bibr">12</xref>,<xref rid="B13-molecules-26-02377" ref-type="bibr">13</xref>,<xref rid="B14-molecules-26-02377" ref-type="bibr">14</xref>] but have been found in other Zingiberaceae plants, including <italic>Z. purpureum</italic> [<xref rid="B14-molecules-26-02377" ref-type="bibr">14</xref>,<xref rid="B20-molecules-26-02377" ref-type="bibr">20</xref>], <italic>Z. montanum</italic> [<xref rid="B22-molecules-26-02377" ref-type="bibr">22</xref>], which is known as &#x0201c;Bangle&#x0201d; or &#x0201c;cassumunar ginger,&#x0201d; <italic>Z. neesanum</italic> [<xref rid="B33-molecules-26-02377" ref-type="bibr">33</xref>], and <italic>Alpinia flabellate</italic> [<xref rid="B34-molecules-26-02377" ref-type="bibr">34</xref>]. Recently, the discovery of phenylbutenoids was reported for the plant of another family, <italic>Dryopteris fragrans</italic> (Dryopteridaceae) [<xref rid="B35-molecules-26-02377" ref-type="bibr">35</xref>].</p><p>Barker et al. [<xref rid="B2-molecules-26-02377" ref-type="bibr">2</xref>] discovered a phenylbutenoid, (<italic>E</italic>)-1-(3&#x02032;,4&#x02032;-dimethoxyphenyl)but-1,3-diene (<bold>1</bold>), in <italic>Z. cassumunar</italic>. Since then, a series of monomers and dimers were isolated from <italic>Z. cassumunar</italic>, and their structures were identified as (<italic>E</italic>)-4-(3&#x02032;,4&#x02032;-dimethoxyphenyl)but-3-en-l-ol (<bold>2</bold>); (<italic>E</italic>)-4-(3&#x02032;,4&#x02032;-dimethoxyphenyl)but-3-en-1-yl acetate (<bold>3</bold>); <italic>cis</italic>-3-(3&#x02032;,4&#x02032;-dimethoxyphenyl)-4-[(<italic>E</italic>)-3&#x02032;&#x02032;&#x02032;,4&#x02032;&#x02032;&#x02032;-dimethoxystyryl]cyclohex-1-ene (<bold>4</bold>); <italic>cis</italic>-3-(3&#x02032;,4&#x02032;-dimethoxyphenyl)-4-[(<italic>E</italic>)-2&#x02032;&#x02032;&#x02032;,4&#x02032;&#x02032;&#x02032;,5&#x02032;&#x02032;&#x02032;-trimethoxystyryl]cyclohex-1-ene (<bold>5</bold>); and <italic>cis</italic>-3-(2&#x02032;,4&#x02032;,5&#x02032;-trimethoxyphenyl)-4-[(<italic>E</italic>)-2&#x02032;&#x02032;&#x02032;,4&#x02032;&#x02032;&#x02032;,5&#x02032;&#x02032;&#x02032;-trimethoxystyryl]cyclohex-l-ene (<bold>6</bold>) [<xref rid="B3-molecules-26-02377" ref-type="bibr">3</xref>]. In a study that further characterized the constituents of <italic>Z. cassumunar</italic>, newly isolated phenylbutenoids, (<italic>E</italic>)-4-(3&#x02032;,4&#x02032;-dimethoxyphenyl)but-3-en-1-yl palmitate (<bold>7</bold>); (<italic>E</italic>)-4-(3&#x02032;-4&#x02032;-dime-thoxyphenyl)but-1-ene (<bold>8</bold>); (<italic>E</italic>)-4-(2&#x02032;,4&#x02032;,5&#x02032;-trimethoxyphenyl)but-1-ene (<bold>9</bold>); <italic>cis</italic>-3-(2&#x02032;,4&#x02032;,5&#x02032;-trimethoxyphenyl)-4-[(<italic>E</italic>)-3&#x02032;&#x02032;&#x02032;,4&#x02032;&#x02032;&#x02032;-dimethoxystyryl]cyclohex-l-ene (<bold>10</bold>); <italic>trans</italic>-3-(3,4-dimethoxyphenyl)-4-[(<italic>E</italic>)-3,4-dimethoxystyryl]cyclohex-1-ene (<bold>11</bold>); <italic>trans</italic>-3-(3&#x02032;,4&#x02032;-dimethoxyphenyl)-4-[(<italic>E</italic>)-2&#x02032;&#x02032;&#x02032;,4&#x02032;&#x02032;&#x02032;,5&#x02032;&#x02032;&#x02032;-trimethoxystyryl]cyclohex-1-ene (<bold>12</bold>); and <italic>trans</italic>-3-(2&#x02032;,4&#x02032;,5&#x02032;-trimethoxyphenyl)-4-[(<italic>E</italic>)-2&#x02032;&#x02032;&#x02032;,4&#x02032;&#x02032;&#x02032;,5&#x02032;&#x02032;&#x02032;-trimethoxystyryl]cyclohex-l-ene (<bold>13</bold>) were reported [<xref rid="B4-molecules-26-02377" ref-type="bibr">4</xref>]. Later, (<italic>E</italic>)-4-(2&#x02032;,4&#x02032;,5&#x02032;-trimethoxyphenyl)but-1,3-diene (<bold>14</bold>) was isolated and identified by Tuntiwatchuntigul et al. [<xref rid="B5-molecules-26-02377" ref-type="bibr">5</xref>]. The isolation of two more phenylbutenoid dimers, <italic>trans</italic>-3-(2&#x02032;,4&#x02032;,5&#x02032;-trimethoxyphenyl)-4-[(<italic>E</italic>)-3&#x02032;&#x02032;&#x02032;,4&#x02032;&#x02032;&#x02032;-dimethoxystyryl]cyclohex-l-ene (<bold>15</bold>) and <italic>cis</italic>-1,2-bis[(<italic>E</italic>)-3,4-dimethoxystyryl]cyclobutane (<bold>16</bold>), was reported [<xref rid="B6-molecules-26-02377" ref-type="bibr">6</xref>]. Phathong et al. [<xref rid="B7-molecules-26-02377" ref-type="bibr">7</xref>] discovered (<italic>E</italic>)-4-(3&#x02032;,4&#x02032;-dimethoxyphenyl)but-3-en-2-ol (<bold>17</bold>) in <italic>Z. cassumunar</italic> [<xref rid="B4-molecules-26-02377" ref-type="bibr">4</xref>]. In our previous phytochemical studies on <italic>Z. cassumunar</italic> [<xref rid="B8-molecules-26-02377" ref-type="bibr">8</xref>,<xref rid="B9-molecules-26-02377" ref-type="bibr">9</xref>], a new dimer type, <italic>trans</italic>-3-(4&#x02032;-hydroxy-3&#x02032;-methoxyphenyl)-4-[(<italic>E</italic>)-3&#x02032;&#x02032;&#x02032;,4&#x02032;&#x02032;&#x02032;-dimethoxystyryl]cyclohex-1-ene (<bold>18</bold>), and a new glycoside type, (<italic>E</italic>)-4-(3&#x02032;,4&#x02032;-dimethoxyphenyl)but-3-en-1-<italic>O</italic>-&#x003b2;-<sub>D</sub>-glucopyranoside (<bold>19</bold>), were isolated from the rhizomes of <italic>Z. cassumunar</italic> collected from Indonesia. Since the naturally occurring phenylbutenoid dimers were identified as racemic mixtures, but biological evaluations have been limited due to their low natural abundance, our research group carried out a total synthesis of optically active phenylbutenoid dimers and produced phenylbutenoid dimers with absolute configurations such as 3<italic>S</italic>-(3,4-dimethoxyphenyl)-4<italic>S</italic>-[(<italic>E</italic>)-3,4-dimethoxystyryl]cyclohex-1-ene (<bold>20</bold>); 3<italic>S</italic>-(3,4-dimethoxyphenyl)-4<italic>R</italic>-[(<italic>E</italic>)-3,4-dimethoxystyryl]cyclohex-1-ene (<bold>21</bold>); and 3<italic>R</italic>-(3,4-dimethoxyphenyl)-4<italic>S</italic>-[(<italic>E</italic>)-3,4-dimethoxystyryl]cyclohex-1-ene (<bold>22</bold>) [<xref rid="B30-molecules-26-02377" ref-type="bibr">30</xref>]. The circular dichroism data for these compounds, for which their absolute configurations were established, have provided an excellent reference for determining the stereochemistry of phenylbutenoid dimers. There have also been reports on the preparative purification of phenylbutenoids from <italic>Z. cassumunar</italic> by countercurrent chromatography (CCC) [<xref rid="B11-molecules-26-02377" ref-type="bibr">11</xref>,<xref rid="B12-molecules-26-02377" ref-type="bibr">12</xref>]. Compounds <bold>1</bold> (175 mg) and <bold>3</bold> (150 mg) at more than 95% purity were successfully separated from the light petroleum extract of <italic>Z. cassumunar</italic> (600 g) using upright CCC in a single step, with the solvent system of light petroleum&#x02012;ethanol&#x02012;dimethyl ether&#x02012;water (5:4:2:1, <italic>v</italic>/<italic>v</italic>) [<xref rid="B11-molecules-26-02377" ref-type="bibr">11</xref>]. This research group further performed elution-extrusion CCC using the <italic>n</italic>-hexane&#x02012;ethyl acetate&#x02012;methanol&#x02012;water (1:1:1:1, <italic>v</italic>/<italic>v</italic>) system for ethanol extraction from this plant, thereby producing milligram-amounts of four phenylbutenoids, (<italic>E</italic>)-4-(3&#x02032;,4&#x02032;-dimethoxyphenyl)but-1,2-diol (<bold>23</bold>); (<italic>E</italic>)-4-(3&#x02032;,4&#x02032;-dimethoxyphenyl)propenal (<bold>24</bold>); <bold>2;</bold> and <bold>3,</bold> which were more than 90% pure, and of a mixture of <bold>4</bold> and <bold>11</bold> [<xref rid="B12-molecules-26-02377" ref-type="bibr">12</xref>]. A pair of diastereoisomers (<bold>4</bold> and <bold>11</bold>) was purified to the (+/&#x02212;)-<italic>trans</italic> form and (+/&#x02212;)-<italic>cis</italic> form at more than 98% pure via second-step separation by CCC. In the phytochemical study of <italic>Z. cassumunar</italic> by Nakamura et al. [<xref rid="B13-molecules-26-02377" ref-type="bibr">13</xref>], six new phenylbutenoids were isolated and named phlains I&#x02012;VI (<bold>25</bold>&#x02012;<bold>30</bold>). Subsequently, Matsuda et al. [<xref rid="B10-molecules-26-02377" ref-type="bibr">10</xref>] reported the isolation and identification of eight new compounds, cassumunols A&#x02012;H (<bold>31</bold>&#x02012;<bold>38</bold>). In the high-performance liquid chromatography/electrospray tandem mass spectroscopy (MS) analyses of phenylbutenoid dimers from <italic>Z. cassumunar</italic> by [<xref rid="B36-molecules-26-02377" ref-type="bibr">36</xref>], two new structures were tentatively identified as <italic>trans</italic>-3-(3&#x02032;,4&#x02032;-dimethoxyphenyl)-4-[(<italic>E</italic>)-4&#x02032;&#x02032;&#x02032;-hydroxy-3&#x02032;&#x02032;&#x02032;-methoxystyryl]cyclohex-1-ene (<bold>39</bold>) and 3-(3&#x02032;,4&#x02032;-dimethoxyphenyl)-4-[(<italic>Z</italic>)-2&#x02032;&#x02032;&#x02032;,4&#x02032;&#x02032;&#x02032;,5&#x02032;&#x02032;&#x02032;-trimethoxystyryl]cyclohex-1-ene (<bold>40</bold>). From Indonesian ginger, Bangle (<italic>Z. purpureum</italic>), a new phenylbutenoid dimer was isolated and identified as banglenol A (<bold>41</bold>) [<xref rid="B14-molecules-26-02377" ref-type="bibr">14</xref>]. These compounds are detailed in <xref ref-type="fig" rid="molecules-26-02377-f002">Figure 2</xref>.</p></sec><sec id="sec2dot2-molecules-26-02377"><title>2.2. Other Compounds</title><p>Curcumin (<bold>42</bold>) is a major compound that was isolated from the rhizomes of <italic>Z. cassumunar</italic> with a yield of more than 0.2% by weight [<xref rid="B13-molecules-26-02377" ref-type="bibr">13</xref>,<xref rid="B15-molecules-26-02377" ref-type="bibr">15</xref>]. The related congeners, cassumunins A&#x02012;C (<bold>43</bold>&#x02012;<bold>45</bold>), were isolated from this plant by Masuda et al. [<xref rid="B16-molecules-26-02377" ref-type="bibr">16</xref>]. Other curcumins, (1<italic>E</italic>,4<italic>E</italic>,6<italic>E</italic>)-1,7-Bis(4-hydroxyphenyl)-1,4,6-heptatrien-3-one (<bold>46</bold>) and bisdeoxycurcumin (<bold>47</bold>), were found in the rhizomes of <italic>Z. cassumunar</italic> [<xref rid="B17-molecules-26-02377" ref-type="bibr">17</xref>]. In addition, two new curcuminoids, neocassumunarin A (<bold>48</bold>) and neocassumunarin B (<bold>49</bold>), were found in Indonesian ginger, Bangle (<italic>Z. purpureum</italic>) [<xref rid="B14-molecules-26-02377" ref-type="bibr">14</xref>]. Two quinones were found in the rhizomes of <italic>Z. cassumunar</italic> and were identified as 2-methoxy-8(3,4-dimethoxyphenyl)-1,4-naphthoquinone (cassumunaquinone 1, <bold>48</bold>) and 2-methoxy-8(2,4,5-trimethoxyphenyl)-1,4-naphthoquinone (cassumunaquinone 2, <bold>49</bold>) [<xref rid="B3-molecules-26-02377" ref-type="bibr">3</xref>,<xref rid="B4-molecules-26-02377" ref-type="bibr">4</xref>,<xref rid="B18-molecules-26-02377" ref-type="bibr">18</xref>]. There are other phenolic compounds in <italic>Z. cassumunar</italic>, such as vanillic acid (<bold>50</bold>); 3,4-dimethoxybenzaldehyde (<bold>51</bold>); 2,4,5-trimethoxybenzaldehyde (<bold>52</bold>); and 1-feruloyloxy cinnamic acid (<bold>53</bold>) [<xref rid="B13-molecules-26-02377" ref-type="bibr">13</xref>,<xref rid="B17-molecules-26-02377" ref-type="bibr">17</xref>]. As for the identification of sesquiterpenoids, zerumbone (<bold>54</bold>) [<xref rid="B37-molecules-26-02377" ref-type="bibr">37</xref>,<xref rid="B38-molecules-26-02377" ref-type="bibr">38</xref>] and &#x003b2;-sesquiphellandrene (<bold>55</bold>) [<xref rid="B13-molecules-26-02377" ref-type="bibr">13</xref>] were isolated from the rhizomes of <italic>Z. cassumunar</italic>, and the essential oil extracted from the leaves of <italic>Z. cassumunar</italic> has been reported to contain 1(10),4-furanodien-6-one (<bold>56</bold>); curzerenone (<bold>57</bold>); and &#x003b2;-sesquiphellandrene [<xref rid="B38-molecules-26-02377" ref-type="bibr">38</xref>]. Pharmaceutical or cosmeceutical products using essential oil from the rhizomes of <italic>Z. cassumunar</italic> have been developed; thus, the chemical composition of essential oil has been analyzed using usually gas chromatography-mass spectrometry (GC&#x02013;MS). Monoterpenoids, sabinene (<bold>58</bold>), and terpinene-4-ol (<bold>59</bold>) were identified as major constituents [<xref rid="B39-molecules-26-02377" ref-type="bibr">39</xref>] in rhizome essential oil, and &#x003b1;-terpinene (<bold>60</bold>), and &#x003b3;-terpinene (<bold>61</bold>) were also discovered [<xref rid="B22-molecules-26-02377" ref-type="bibr">22</xref>,<xref rid="B40-molecules-26-02377" ref-type="bibr">40</xref>]. In addition to these components, the essential oil produced by steam contained approximately 25% phenylbutenoids, and oil extracted with light petroleum contained approximately 46% phenylbutenoids [<xref rid="B41-molecules-26-02377" ref-type="bibr">41</xref>]. These compounds are presented in <xref ref-type="fig" rid="molecules-26-02377-f003">Figure 3</xref>.</p></sec></sec><sec id="sec3-molecules-26-02377"><title>3. Bioactivities of Extracts and Compounds from <italic>Z. cassumunar</italic></title><p><xref rid="molecules-26-02377-t001" ref-type="table">Table 1</xref> summarizes the various bioactivities of the extracts, solvent fractions, and compounds from <italic>Z. cassumunar</italic> that have been reported. Their pharmacological and nutraceutical properties as derived from the results of the bioassay, in vitro mechanism of action, or in vivo experiments are described in detail below.</p><sec id="sec3dot1-molecules-26-02377"><title>3.1. Antioxidant Activities</title><p>It was discovered that curcuminoids isolated from <italic>Z. cassumunar</italic>, cassumunin A (<bold>43</bold>), and cassumunin B (<bold>44</bold>), prevent the H<sub>2</sub>O<sub>2</sub>-induced decrease in cell viability of thymocytes and protect living cells that are suffering from H<sub>2</sub>O<sub>2</sub>-induced oxidative stress [<xref rid="B42-molecules-26-02377" ref-type="bibr">42</xref>]. The essential oil from <italic>Z. cassumunar</italic> contains three major components, sabinene, terpinen-4-ol, and (<italic>E</italic>)-1-(3,4-dimethyoxyphenyl)but-1,3-diene, which exhibited antioxidant activity upon scavenging the 2,2&#x02032;-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid (ABTS) cation radical and demonstrated H<sub>2</sub>O<sub>2</sub> scavenging activity when emissions of dichlorodihydrofluorescein-fluorescence were reduced within a monocyte cell line (U937) [<xref rid="B38-molecules-26-02377" ref-type="bibr">38</xref>]. In a study on the evaluation of solvent fractions of <italic>Z. cassumunar</italic> on in vitro antioxidant and &#x003b1;-glucosidase inhibitory assay [<xref rid="B43-molecules-26-02377" ref-type="bibr">43</xref>], the chloroform fraction showed 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity with an IC<sub>50</sub> value of 78.19 &#x003bc;g/mL, while the hexane fraction demonstrated H<sub>2</sub>O<sub>2</sub> scavenging activity with an IC<sub>50</sub> value of 34.40 &#x003bc;g/mL and &#x003b1;-glucosidase inhibitory activities with an IC<sub>50</sub> value of 61.02 &#x003bc;g/mL. The ethanol extract of the <italic>Z. cassumunar</italic> rhizome with 7% curcumin content was evaluated for its effect on superoxide dismutase (SOD) enzyme activity in rats fed a high-fat diet (HFD), which resulted in increased SOD activity upon oral administration of the extract (400 mg/kg, o.p.) in rats fed an HFD, compared to the control group and HFD group, which indicated that the <italic>Z. cassumunar</italic> rhizome has antioxidant activity and an ameliorate reactive oxygen species effect caused by HFD [<xref rid="B44-molecules-26-02377" ref-type="bibr">44</xref>]. Therefore, in vitro and in vivo studies demonstrated that curcuminoids and essential oil from <italic>Z. cassumunar</italic> have strong antioxidant activities.</p></sec><sec id="sec3dot2-molecules-26-02377"><title>3.2. Anti-Inflammatory Activities</title><p>The anti-inflammatory activities of the extracts and constituents of <italic>Z. cassumunar</italic> were investigated in carrageenin-induced edema in rats and acetic acid-induced vascular permeability and writhing symptoms in mice [<xref rid="B46-molecules-26-02377" ref-type="bibr">46</xref>]. Oral administration of methanol extract (3 g/kg) exhibited anti-inflammatory activity against edema and reduced the number of writhes induced by acetic acid. Oral administration of methanol extract (1 g/kg), ether-soluble fraction (1.3 g/kg), <italic>n</italic>-hexane-soluble fraction (0.2 g/kg), and (<italic>E</italic>)-1-(3&#x02032;,4&#x02032;-dimethoxyphenyl)but-1-ene (<bold>8</bold>) (0.016 g/kg) impacted vascular permeability induced by acetic acid in mice. In an assessment of the topical anti-inflammatory activities of the essential oil of <italic>Z. cassumunar</italic> rhizomes and its major components [<xref rid="B40-molecules-26-02377" ref-type="bibr">40</xref>], a topical application of the essential oil inhibited the development of edema induced by carrageenan with an ID<sub>50</sub> value of 22 mg/paw, and an ID<sub>50</sub> value of (<italic>E</italic>)-1-(3&#x02032;,4&#x02032;-dimethoxyphenyl)but-1-ene (<bold>8</bold>) was estimated to be 3 mg/paw (diclofenac, ID<sub>50</sub> 6 mg/paw). Terpine-4-ol (<bold>59</bold>) and &#x003b1;-terpinene (<bold>60</bold>) showed approximately 40% and 30% inhibition at the highest dose tested (6 mg/paw), respectively. Other tested compounds, sabinene (<bold>58</bold>) and &#x003b3;-terpinene (<bold>61</bold>), were inactive. In addition, the hexane fraction of <italic>Z. cassumunar</italic> removing the essential oil was tested in the model of 12-<italic>O</italic>-tetradecanoylphorbol-13-acetate(TPA)-induced ear edema in rats and showed an effect with an ID<sub>50</sub> value of 854 &#x003bc;g/ear [<xref rid="B48-molecules-26-02377" ref-type="bibr">48</xref>]. The isolates, (<italic>E</italic>)-4-(3&#x02032;,4&#x02032;-dimethoxyphenyl)but-3-en-1-ol (<bold>2</bold>), (<italic>E</italic>)-4-(3&#x02032;,4&#x02032;-dimethoxyphenyl)but-3-enyl acetate (<bold>3</bold>); <italic>cis</italic>-3-(3&#x02032;,4&#x02032;-dimethoxyphenyl)-4-[(<italic>E</italic>)-3&#x02032;&#x02032;&#x02032;,4&#x02032;&#x02032;&#x02032;-dimethoxystyryl]cyclohex-1-ene (<bold>4</bold>); <italic>cis</italic>-3-(3&#x02032;,4&#x02032;-dimethoxyphenyl)-4-[(<italic>E</italic>)-2&#x02032;&#x02032;&#x02032;,4&#x02032;&#x02032;&#x02032;,5&#x02032;&#x02032;&#x02032;-trimethoxystyryl]cyclohex-1-ene (<bold>5</bold>); and <italic>cis</italic>-3-(2&#x02032;,4&#x02032;,5&#x02032;-trimethoxyphenyl)-4-[(<italic>E</italic>)-2&#x02032;&#x02032;&#x02032;,4&#x02032;&#x02032;&#x02032;,5&#x02032;&#x02032;&#x02032;- trimethoxystyryl]cyclohex-1-ene (<bold>6</bold>) from this fraction exerted topical anti-inflammatory activities with ID<sub>50</sub> values of 47, 62, 21, 20, and 2 &#x003bc;g/ear, respectively (diclofenac, ID<sub>50</sub> 61 &#x003bc;g/ear). Further investigation of the anti-inflammatory activity of (<italic>E</italic>)-1-(3&#x02032;,4&#x02032;-dimethoxyphenyl)but-1,3-diene (<bold>1</bold>) using the in vivo and in vitro model suggested the effect of this compound on cyclooxygenase (COX) and lipoxygenase pathways [<xref rid="B55-molecules-26-02377" ref-type="bibr">55</xref>]. This compound inhibited the rat ear edema induced by ethyl phenylpropiolate (EPP), arachidonic acid (AA), and TPA with IC<sub>50</sub> values of 21, 60, and 660 nmol/ear. The rat paw edema induced by carrageenan was also inhibited by <bold>1</bold> with IC<sub>50</sub> at 3 h of 22 &#x003bc;mol/paw. Compound <bold>1</bold> inhibited the platelet aggregation induced by collagen, adenosine diphosphate (ADP), AA, and the platelet-activating factor (PAF) with IC<sub>50</sub> values of 0.35, 4.85, 0.94, and 1.14 mM. The anti-inflammatory activity of (<italic>E</italic>)-1-(3&#x02032;,4&#x02032;-dimethoxyphenyl)but-3-en-2-ol (<bold>17</bold>) has been investigated in several in vivo models [<xref rid="B7-molecules-26-02377" ref-type="bibr">7</xref>]. Compound <bold>17</bold> reduced carrageenin-induced paw edema in rats by 83.9% at a dose of 300 mg/kg. In a test of the effect of <bold>17</bold> on carrageenin-induced rat pleurisy, <bold>17</bold> showed inhibitory activities against the formation of pleural exudate (52.3%) in the accumulation of leukocytes in the pleural exudate (56.5%), and in prostaglandin E<sub>2</sub>-like substances that were present in the inflamed exudate (48.8%). Compound <bold>17</bold> exhibited slight inhibitory effects on adjuvant-induced arthritis in primary (15.8%) and secondary lesions (injected [14.5%] and no injected paws [20.0%]). The analgesic properties of <bold>17</bold> were tested using an acetic acid-induced writhing response in mice and tail-flick test in rats, which exerted inhibitory activities on the writhing response and tail-flick response to radiant heat, with inhibitions of 52.0% and 11.7% at a dosage of 300 mg/kg (i.g.). Compound <bold>17</bold> showed an antipyretic effect by reducing the rectal temperature at a low dose of 75 mg/kg (i.g.) in yeast-induced hyperthermia in rats. In our previous study on the anti-inflammatory effects of phenylbutenoids from <italic>Z. cassumunar</italic> [<xref rid="B9-molecules-26-02377" ref-type="bibr">9</xref>], four compounds, <italic>trans</italic>-3-(3,4-dimethoxyphenyl)-4-[(E)-3,4-dimethoxystyryl]cyclohex-1-ene (<bold>11</bold>); <italic>trans</italic>-3-(4&#x02032;-hydroxy-3&#x02032;-methoxyphenyl)-4-[(<italic>E</italic>)-3&#x02032;&#x02032;&#x02032;,4&#x02032;&#x02032;&#x02032;-dimethoxystyryl]cyclohex-1-ene (<bold>18</bold>); (<italic>E</italic>)-4-(2&#x02032;,4&#x02032;,5&#x02032;-trimethoxyphenyl)but-1,3-diene (<bold>14</bold>); and (<italic>E</italic>)-1-(3&#x02032;,4&#x02032;-dimethoxyphenyl)but-1,3-diene (<bold>1</bold>) demonstrated inhibitory activities with IC<sub>50</sub> values of 2.71, 3.64, 14.97, and 20.68 &#x003bc;M, respectively (celecoxib; IC<sub>50</sub> 0.52 nM), in the COX-2 inhibitory assay by measuring prostaglandin E<sub>2</sub> (PGE<sub>2</sub>) production in lipopolysaccharide (LPS)-stimulated mouse macrophage RAW264.7 cells. Another study examined the inhibitory effects of the constituents of <italic>Z. cassumunar</italic> on LPS-induced nitric oxide (NO) production in mouse peritoneal macrophages [<xref rid="B13-molecules-26-02377" ref-type="bibr">13</xref>]. Compounds, plain I (<bold>25</bold>); plain III (<bold>27</bold>); plain VI (<bold>30</bold>); (<italic>E</italic>)-1-(3&#x02032;,4&#x02032;-dimethoxyphenyl)but-1,3-diene (<bold>1</bold>); (<italic>E</italic>)-4-(2&#x02032;,4&#x02032;,5&#x02032;-trimethoxyphenyl)but-1,3-diene (<bold>14</bold>); (<italic>E</italic>)-4-(2&#x02032;,4&#x02032;,5&#x02032;-trimethoxyphenyl)but-1-ene (<bold>9</bold>); cassumunaquinone 2 (<bold>49</bold>); curcumin (<bold>42</bold>); and &#x003b2;-sesquiphellandrene (<bold>55</bold>) exhibited inhibitory effects with IC<sub>50</sub> values of 24, 24, 50, 69, 83, 31, 47, 11, and 52 &#x003bc;M, respectively (caffeic acid phenyl ester; IC<sub>50</sub> 16 &#x003bc;M). In a study comparing the anti-inflammatory effects of a phenylbutenoid-rich fraction of <italic>Z. cassumunar</italic> with four individual phenylbutenoids and other crude extracts according to different extraction methods [<xref rid="B45-molecules-26-02377" ref-type="bibr">45</xref>], the phenylbutenoid-rich fraction exhibited the strongest inhibitory activity on LPS-induced NO production in murine macrophage RAW264.7 cells. The phenylbutenoid-rich fraction prepared by one-step silica&#x02013;gel column chromatography on the hexane extract exhibited an NO inhibitory effect with an IC<sub>50</sub> value of 4.6 &#x003bc;g/mL, whereas hexane extracted under reflux and the essential oil obtained by a hydrodistillation inhibited NO production with IC<sub>50</sub> values of 11.9 and 21.5&#x003bc;g/mL, respectively. The compounds (<italic>E</italic>)-4-(3,4-dimethoxyphenyl)but-3-en-l-ol (<bold>2</bold>); (<italic>E</italic>)-4-(3,4-dimethoxyphenyl)but-3-en-l-yl acetate (<bold>3</bold>); (<italic>E</italic>)-1-(3,4-dimethoxyphenyl)but-1,3-diene (<bold>1</bold>); and (<italic>E</italic>)-3-(3,4-dimethoxyphenyl)-4-[(<italic>E</italic>)-3,4-dimethoxystyryl]cyclohex-1-ene (<bold>4</bold> or <bold>11</bold>) displayed IC<sub>50</sub> values of 211.1, 86.8, 56.3, and 39.7 &#x003bc;M, respectively (caffeic acid phenyl ester; IC<sub>50</sub> 5.6 &#x003bc;M). In an assessment of the anti-inflammatory effects of the constituents of <italic>Z. cassumunar</italic> in human dental pulp cells [<xref rid="B49-molecules-26-02377" ref-type="bibr">49</xref>], <italic>cis</italic>-3-(3&#x02032;,4&#x02032;-dimethoxyphenyl)-4-[(<italic>E</italic>)-3&#x0201d;&#x02018;,4&#x0201d;&#x02018;-dimethoxystyryl]cyclohex-1-ene (<bold>4</bold>); <italic>cis</italic>-3-(2&#x02032;,4&#x02032;,5&#x02032;-trimethoxyphenyl)-4-[(E)-2&#x0201d;&#x02018;,4&#x0201d;&#x02018;,5&#x0201d;&#x02018;-trimethoxystyryl]cyclohex-1-ene (<bold>6</bold>); and (<italic>E</italic>)-1-(3&#x02032;,4&#x02032;-dimethoxyphenyl)but-1,3-diene (<bold>1</bold>) reduced the LPS-induced PGE2 level and COX-2 expression in human dental pulp cells.</p><p><italic>Z. cassumunar</italic> was traditionally used to release pain in osteoarthritis and rheumatoid arthritis. Two constituents of this plant, c<italic>is</italic>-3-(2&#x02032;,4&#x02032;,5&#x02032;-trimethoxyphenyl)-4-[(<italic>E</italic>)-2&#x02032;&#x02019;&#x02019;,4&#x02032;&#x02019;&#x02019;,5&#x02032;&#x02019;&#x02019;-trimethoxystyryl]cyclohex-l-ene (<bold>5</bold>) and (<italic>E</italic>)-4-(3&#x02032;,4&#x02032;-dimethoxyphenyl)but-3-en-l-ol (<bold>2</bold>), each at a concentration of 100 &#x003bc;M, were found to possess chondroprotective effects against cytokine-induced cartilage degradation in the explant culture [<xref rid="B50-molecules-26-02377" ref-type="bibr">50</xref>]. These two compounds inhibited the release of sulfated glycosaminoglycans and hyaluronic acid induced by Interleukin-1&#x003b2; (IL-1&#x003b2;) and suppressed IL-1&#x003b2;-induced loss of collagen and uronic acid contents from cartilage explants. The activities of matrix metalloproteinase (MMP)-2 and MMP-13 induced by IL-1&#x003b2; were reduced by 5 and 7. In a later study by Chaiwongsa et al. [<xref rid="B51-molecules-26-02377" ref-type="bibr">51</xref>], (<italic>E</italic>)-4-(3&#x02032;,4&#x02032;-dimethoxyphenyl)but-3-en-l-ol (<bold>2</bold>) was found to downregulate the expression of MMPs (MMP-1, -2, -3, and -13) induced by IL-1&#x003b2; in a human synovial fibroblast SW982 cell line. Increases in the expressions of IL-1&#x003b2; and the IL-1&#x003b2;-converting enzyme were also inhibited by compound <bold>2</bold>.</p><p>The rhizomes of <italic>Z. cassumunar</italic> were used as an anti-asthmatic drug in Thai traditional medicine. There have been reports on the pharmacokinetic studies of (<italic>E</italic>)-4-(3&#x02032;,4&#x02032;-dimethoxyphenyl)but-3-en-1-ol (<bold>2</bold>), which has anti-inflammatory action [<xref rid="B56-molecules-26-02377" ref-type="bibr">56</xref>,<xref rid="B57-molecules-26-02377" ref-type="bibr">57</xref>]. The pharmacokinetics of <bold>2</bold> were studied in rats and monkeys using the in situ intestinal loop technique for asthmatic treatment [<xref rid="B23-molecules-26-02377" ref-type="bibr">23</xref>]. The absorption of this compound reached its maximum at approximately 1 h after oral administration in rats and also exhibited an elimination half-life of approximately 2&#x02013;2.3 h in both animal models. In addition, the pharmacokinetic profiles of <bold>2</bold>, including absorption, tissue distribution, and route of elimination, in male Wistar rats were also examined [<xref rid="B24-molecules-26-02377" ref-type="bibr">24</xref>]. The compound showed good absorption, which reached its maximum at approximately 0.15 h after drug administration, and an excellent ratio of tissue to plasma that ranged from 1 to 1,000 in organs at 1&#x02012;4 h after drug administration. Less than 1% of <bold>2</bold> was detected in feces and urine. The ethanol extract of <italic>Z</italic>. <italic>cassumunar</italic> (5&#x02013;100 &#x003bc;g/mL) significantly inhibited total mucin production, including MUC2 and MUC5AC mRNA and proteins induced by phorbol12-myristate 13-acetate (PMA) in human airway epithelial NCI-H292 cells [<xref rid="B47-molecules-26-02377" ref-type="bibr">47</xref>]. The extracts also inhibited phosphorylation of extracellular signal-regulated kinase but not JNK and p38 in PMA-stimulated NCI-H292 cells. In the follow-up study [<xref rid="B52-molecules-26-02377" ref-type="bibr">52</xref>], the ethanol extract and (<italic>E</italic>)-4-(3&#x02032;,4&#x02032;-dimethoxyphenyl)but-3-en-1-ol (<bold>2</bold>) from <italic>Z. cassumunar</italic> inhibited pro-MMP-9 cleavage by MMP-9 in asthma induced by house dust mite allergens. The extracts (100 mg/mL) and compound D (50 and 100 mg/mL) attenuated the PMA-induced MMP-9 gene and expression in NCI-H292 cells. Recently, the analysis of molecular interactions between two constituents of Z. <italic>cassumunar</italic> and a protein target, the 5-lipoxygenase (5-LO) enzyme, involved with asthma symptoms, were studied using molecular docking and molecular dynamics simulations [<xref rid="B53-molecules-26-02377" ref-type="bibr">53</xref>]. (<italic>E</italic>)-1-(3&#x02032;,4&#x02032;-Dimethoxyphenyl)buta-1,3-diene (<bold>1</bold>) and (<italic>E</italic>)-4-(3&#x02032;,4&#x02032;-dimethoxyphenyl)but-3-en-1-ol (<bold>2</bold>) bound at the same catalytic site of its natural substrate (AA) on the 5-LO enzyme. The binding energy calculations of the 5-LO complex with <bold>1</bold>, <bold>2</bold>, and zileuton (anti-asthma agent) were &#x02212;29.15, &#x02212;26.83, and &#x02212;29.40 kcal/mol, respectively, which supports the competition between the <bold>1</bold> and <bold>2</bold> substrate inhibitors, which was the same as zileuton [<xref rid="B53-molecules-26-02377" ref-type="bibr">53</xref>]. Overall, these accumulated results indicated that the extracts and components of the <italic>Z. cassumunar</italic> possess potential value in the prevention and treatment of various diseases related to inflammation.</p></sec><sec id="sec3dot3-molecules-26-02377"><title>3.3. Anticancer Activities</title><p>Our research group has long carried out a series of studies on the anticancer activities of various components of <italic>Z cassumunar</italic>&#x02014;from extracts to isolates [<xref rid="B8-molecules-26-02377" ref-type="bibr">8</xref>,<xref rid="B15-molecules-26-02377" ref-type="bibr">15</xref>,<xref rid="B40-molecules-26-02377" ref-type="bibr">40</xref>,<xref rid="B41-molecules-26-02377" ref-type="bibr">41</xref>,<xref rid="B42-molecules-26-02377" ref-type="bibr">42</xref>,<xref rid="B43-molecules-26-02377" ref-type="bibr">43</xref>,<xref rid="B44-molecules-26-02377" ref-type="bibr">44</xref>,<xref rid="B45-molecules-26-02377" ref-type="bibr">45</xref>,<xref rid="B46-molecules-26-02377" ref-type="bibr">46</xref>,<xref rid="B47-molecules-26-02377" ref-type="bibr">47</xref>]. The chloroform-soluble fraction of <italic>Z. cassumunar</italic> was found to have cytotoxicity against two human cancer cell lines (A549, lung; SNU-638, stomach) with IC<sub>50</sub> values of 18.5 and 11.3 &#x000b5;g/mL, respectively [<xref rid="B25-molecules-26-02377" ref-type="bibr">25</xref>]. Bioassay-guided fractionation of this fraction led to the isolation of several phenylbutenoids, and the cytotoxicities of these compounds have been evaluated against several human cancer cell lines (A549, lung; Col2, colon; SNU-638, stomach; HT-1080, fibrosarcoma) [<xref rid="B8-molecules-26-02377" ref-type="bibr">8</xref>,<xref rid="B15-molecules-26-02377" ref-type="bibr">15</xref>]. Compounds <italic>trans</italic>-3-(3,4-dimethoxyphenyl)-4-[(E)-3,4-dimethoxystyryl]cyclohex-1-ene (<bold>11</bold>) and <italic>trans</italic>-3-(4&#x02032;-hydroxy-3&#x02032;-methoxyphenyl)-4-[(<italic>E</italic>)-3&#x02032;&#x02032;&#x02032;,4&#x02032;&#x02032;&#x02032;-dimethoxystyryl]cyclohex-1-ene (<bold>18</bold>) exhibited moderate cytotoxicity against all tested human cancer cell lines, whereas (<italic>E</italic>)-1-(3&#x02032;,4&#x02032;-dimethoxyphenyl)but-1,3-diene (<bold>1</bold>) showed significant cytotoxicity against HT-1080 cells (IC<sub>50</sub> value of 7.9 &#x000b5;M) in a selective manner. In a further mechanism study on the antiproliferative effect of <bold>2</bold> in A549 cells [<xref rid="B26-molecules-26-02377" ref-type="bibr">26</xref>], <italic>trans</italic>-3-(3,4-dimethoxyphenyl)-4-[(E)-3,4-dimethoxystyryl]cyclohex-1-ene (<bold>11</bold>) induced G0/G1 phase cell cycle arrest by downregulating the expression of cyclin-dependent kinases (CDKs) and cyclins and by suppressing CDK activity via the induction of p21 expression. In addition, our research group has screened the P-glycoprotein (P-gp) inhibitory activities of four solvent fractions (hexanes, chloroform, <italic>n</italic>-butanol, and aqueous) of Indonesian medicinal plants in P-gp overexpressing multidrug resistance (MDR) cancer cell lines (MES-SA/DX5, uterine; MCF-7/ADR, breast) [<xref rid="B27-molecules-26-02377" ref-type="bibr">27</xref>,<xref rid="B28-molecules-26-02377" ref-type="bibr">28</xref>]. The hexane fraction of <italic>Z. cassumunar</italic> exhibited potent P-gp inhibitory activity with a daunomycin (DNM) IC<sub>50</sub> value of 0.93 &#x003bc;g/mL in the MES-SA/DX5 cell line, compared with that of verapamil, which is a well-known P-gp inhibitor (IC<sub>50</sub> 1.4 &#x003bc;M) [<xref rid="B27-molecules-26-02377" ref-type="bibr">27</xref>], and the chloroform fraction decreased the cytotoxicity of DNM with up to a 6.56 &#x003bc;g/mL IC<sub>50</sub> value in the MCF-7/ADR cell line (verapamil, IC<sub>50</sub> 6.62 &#x003bc;M) [<xref rid="B28-molecules-26-02377" ref-type="bibr">28</xref>]. In our follow-up study on the P-gp inhibitory effect of the constituent of <italic>Z. cassumunar</italic> [<xref rid="B29-molecules-26-02377" ref-type="bibr">29</xref>], <italic>trans</italic>-3-(3,4-dimethoxyphenyl)-4-[(<italic>E</italic>)-3,4-dimethoxystyryl]cyclohex-1-ene (<bold>11</bold>) exhibited potent P-gp inhibitory activity when the IC<sub>50</sub> value of DNM was decreased by more than that of verapamil. Particularly, <bold>11</bold> showed greater enhancement of [<sup>3</sup>H]-DNM accumulation and the attenuation of the [<sup>3</sup>H]-DNM efflux compared to those of verapamil. (<italic>E</italic>)-1-(3&#x02032;,4&#x02032;-dimethoxyphenyl)but-1,3-diene (<bold>1</bold>) and (<italic>E</italic>)-4-(2&#x02032;,4&#x02032;,5&#x02032;-trimethoxyphenyl)but-1,3-diene (<bold>14</bold>), having two double bonds in the butane chain, significantly decreased the IC<sub>50</sub> value of DNM, while (<italic>E</italic>)-4-(3&#x02032;,4&#x02032;-dimethoxyphenyl)but-3-en-1-ol (<bold>2</bold>) and (<italic>E</italic>)-4-(3&#x02032;,4&#x02032;-dimethoxyphenyl)but-3-enyl acetate (<bold>3</bold>) with one double bond in their structures showed a weak decrease of those. Compound <bold>11</bold> was discovered to be a potent modulator of P-gp activity but was isolated as a racemic mixture. However, since the pharmacological effects and pharmacokinetic properties of the racemic mixture could be different from those of the respective enantiomers, 3<italic>S</italic>-(3,4-dimethoxyphenyl)-4<italic>R</italic>-[(<italic>E</italic>)-3,4-dimethoxystyryl]cyclohex-1-ene (<bold>21</bold>) and 3<italic>R</italic>-(3,4-dimethoxyphenyl)-4<italic>S</italic>-[(<italic>E</italic>)-3,4-dimethoxystyryl]cyclohex-1-ene (<bold>22</bold>), which were optically and actively synthesized by our research group, were evaluated for their P-gp inhibitory effects in the MCF-7/ADR cell line, in which they exhibited DNM cytotoxicities with IC<sub>50</sub> values of 1.44 &#x003bc;M and 3.19 &#x003bc;M [<xref rid="B30-molecules-26-02377" ref-type="bibr">30</xref>]. Then, we identified their mechanism of action by measuring the cellular accumulation and efflux of DNM, human P-gp membrane ATPase activity, and cellular P-gp expression [<xref rid="B31-molecules-26-02377" ref-type="bibr">31</xref>]. Compound <bold>22</bold> significantly changed the ratio of [<sup>3</sup>H]-DNM accumulation (539%) and efflux (55.4%), compared to those of <bold>21</bold>; thus, the in vivo application of <bold>22</bold> coadministrated with paclitaxel (a P-gp specific substrate) was investigated. When paclitaxel (25 mg/kg) was orally administered with 2 (5 mg/kg), its relative bioavailability was improved by 185% due to the oral exposure of paclitaxel through the inhibition of the intestinal P-gp. In our recent study, which aimed to discover an inhibitor of metastasis from phenylbutenoid and its derivatives [<xref rid="B32-molecules-26-02377" ref-type="bibr">32</xref>], it was discovered that <italic>trans</italic>-3-(3,4-dimethoxyphenyl)-4-[(<italic>E</italic>)-3,4-dimethoxystyryl]cyclohex-1-ene (<bold>11</bold>) activated the nucleoside diphosphate kinase (NDPK) activity of recombinant Nm23-H1 (a tumor metastasis suppressor) in a dose-dependent manner (EC<sub>50</sub>, 10.7 &#x003bc;M). Compound <bold>11</bold> was shown to bind to the C-terminal of Nm23-H1 and to induce NDPK activation through allosteric conformational changes via an in silico molecular docking analysis. This compound induced morphological changes in a highly invasive breast cancer MDA-MB-231 cell line and reduced Rac1 activation via NDPK activation of Nm23-H1. This compound also suppressed the in vitro invasion and migration of MDA-MB-231 cells and in vivo metastasis in a breast cancer mouse model (a luciferase-expressing metastatic human breast cancer cell (MDA-MB-231-Luc-D3H2LN) implanted in nonobese diabetic/severe combined immune-deficient (NOD/SCID) mice). Matsuda et al. [<xref rid="B10-molecules-26-02377" ref-type="bibr">10</xref>] elucidated the inhibitory effects of several phenylbutenoids from <italic>Z. cassumunar</italic> on the invasion of human fibrosarcoma HT-1080 cells. Plain I (<bold>25</bold>); plain III (<bold>27</bold>); (<italic>E</italic>)-1-(3&#x02032;,4&#x02032;-dimethoxyphenyl)but-1,3-diene (<bold>1</bold>); (<italic>E</italic>)-4-(2&#x02032;,4&#x02032;,5&#x02032;-trimethoxyphenyl)but-1,3-diene (<bold>14</bold>); and &#x003b2;-sesquiphellandrene (<bold>55</bold>) have shown anti-invasive activities with the inhibition of 40.5%, 33.0%, 46.8%, 45.5%, and 29.0% at 30 &#x003bc;g/mL, respectively, compared with the positive control, deguelin with the inhibition of 57.9% at the same concentration. Among them, compound <bold>14</bold> significantly inhibited the invasion of HT-1080 cells, which was determined by very weak cytotoxicity. There was a study on the mechanisms of apoptosis induced by an abundant phenylbutenoid dimer in <italic>Z. cassumunar</italic>, <italic>cis</italic>-3-(3&#x02032;,4&#x02032;-dimethoxyphenyl)-4-[(<italic>E</italic>)-3&#x02032;&#x02019;&#x02019;,4&#x02032;&#x02019;&#x02019;-dimethoxystyryl]cyclohex-1-ene (<bold>4</bold>), toward the T-acute lymphoblastic leukemia CEMss cell line [<xref rid="B54-molecules-26-02377" ref-type="bibr">54</xref>]. This compound exerted potent antiproliferative activity toward CEMss cells with an IC<sub>50</sub> value of 7.11 &#x003bc;g/mL, followed by hepatocellular carcinoma (HepG2), human breast adenocarcinoma (MCF-7), human breast carcinoma (MDA-MB-231), cervical carcinoma (HeLa), and human blood mononuclear cells with IC<sub>50</sub> values of 17.65, 21.28, 32.38, &#x0003e;50, and &#x0003e;50 &#x003bc;g/mL, respectively. The effect of <bold>4</bold> on the morphology of CEMss cells exhibited significant morphological changes corresponding to typical apoptosis. Compound <bold>4</bold> also showed a significant S phase arrest and triggered the formation of DNA fragmentation in CEMss cells. A decline in the MMP of CEMss cells by <bold>4</bold> was detected. After screening several proteins implicated in apoptosis induction, it was determined that <bold>4</bold> upregulated the Bcl-2-associated X protein (Bax), caspase-3, cytochrome c, and the second mitochondria-derived activator of caspase and downregulated B-cell lymphoma 2 (Bcl-2), heat shock protein 70, and X-linked inhibitor of apoptosis protein but did not affect caspase-8, p53, and the BH3 interacting domain death agonist. The activity of caspases-3/7 and -9 involved in the intrinsic pathway was increased in CEMss cells treated with <bold>4</bold>. Thus, <bold>4</bold> exhibited an apoptogenic property in the CEMss cell line via the intrinsic mitochondrial pathway of apoptosis induction. Previous results demonstrated that phenylbutenoids from <italic>Z. cassumunar</italic> possess potent anticancer activities via their preventive efficacy on MDR in chemotherapy, as well as the effects of treating cancer caused by multiple carcinogeneses, such as antiproliferative, antimetastatic, and anti-apoptotic activities in cancer.</p></sec><sec id="sec3dot4-molecules-26-02377"><title>3.4. Neuroprotective and Neurotrophic Activities</title><p>In an assessment of the protective effect of the ethanol extract of <italic>Z. cassumunar</italic> against LPS-induced neuronal cell loss and the activation of astrocytes in the hippocampus [<xref rid="B19-molecules-26-02377" ref-type="bibr">19</xref>], pretreatment with <italic>Z. cassumunar</italic> extract (200 mg/kg, i.p.) in adult male Wistar rats reduced neuronal cell loss in the hippocampus and suppressed the inflammatory response by reducing the expression of the glial fibrillary acidic protein and IL-1ss in the hippocampus. The constituents of Indonesian ginger, Bangle (<italic>Z. purpureum</italic>), demonstrated neurotrophic effects in a series of studies [<xref rid="B14-molecules-26-02377" ref-type="bibr">14</xref>,<xref rid="B20-molecules-26-02377" ref-type="bibr">20</xref>]. <italic>Trans</italic>-3-(3&#x02032;4&#x02032;-dimethoxyphenyl)-4-[(E)-3&#x02032;&#x02032;,4&#x02032;&#x02032;-dimethoxystyryl]cyclohex-1-ene (<bold>11</bold>), and <italic>cis</italic>-3-(3&#x02032;4&#x02032;-dimethoxyphenyl)-4-[(E)-3&#x02032;&#x02032;,4&#x02032;&#x02032;-dimethoxystyryl]cyclohex-1-ene (<bold>4</bold>) have exerted neurotrophic effects by inducing neurite sprouting in PC12 cells and triggering neurogenesis and neurite growth and protection in primary cultured rat cortical neurons. Chronic treatment of these compounds (50 mg/kg, p.o.) enhanced hippocampal neurogenesis in olfactory bulbectomy (OBX)-induced mice and increased the number of 5-bromo-2&#x02032;-deoxyuridine (BrdU)/NeuN (a neuronal marker) double-labeled cells [<xref rid="B20-molecules-26-02377" ref-type="bibr">20</xref>]. In addition, two curcuminoids, neocassumunarins A (<bold>48</bold>) and B (<bold>49</bold>), also promoted neurite outgrowth of nerve growth factor (NGF)-mediated PC12 cells in concentrations ranging from 1 to 10 &#x003bc;M [<xref rid="B14-molecules-26-02377" ref-type="bibr">14</xref>]. It was discovered that compound <bold>48</bold> prevents &#x003b2;-sheet formation in the amyloid b-protein (A&#x003b2;42). Therefore, the above results indicate that phenylbutenoid dimers have therapeutic potential for treating depression and dementia, such as Alzheimer&#x02019;s disease.</p></sec><sec id="sec3dot5-molecules-26-02377"><title>3.5. Dermatological Activities</title><p>In our previous study on <italic>Z. cassumunar</italic>, one of its constituents, (<italic>E</italic>)-4-(3,4-dimethoxyphenyl)but-3-en-1-ol (<bold>2</bold>), was discovered to enhance melanogenesis through increasing upstream stimulating factor-1-mediated expressions of ERK, p38, and tyrosinase in the mouse melanoma B16 F10 cell line and to induce hyperpigmentation in brown guinea pigs in vivo [<xref rid="B21-molecules-26-02377" ref-type="bibr">21</xref>]. In another study that aimed to identify the cosmetic potential of this plant [<xref rid="B17-molecules-26-02377" ref-type="bibr">17</xref>], its rhizome extracts and components were evaluated for their DPPH radical scavenging, HDFa collagen secretion promotion, tyrosinase inhibition, and inhibition of LPS-induced NO production in RAW264.7 cells. The ethyl acetate extract showed greater activities in this four-assay system compared to those of the petroleum ether and chloroform extracts of the plant. Among the six constituents of the plant, the HDFa collagen secretion promoting activity of <italic>cis</italic>-3-(3,4-dimethoxyphenyl)-4-[(<italic>E</italic>)-2,4,5-trimehoxystyryl]cyclohex-1-ene (<bold>5</bold>) and (1<italic>E</italic>,4<italic>E</italic>,6<italic>E</italic>)-1,7-bis(4-hydroxyphenyl)-1,4,6-heptatrien-3-one (<bold>46</bold>), the tyrosinase inhibiting activity of <bold>46</bold>, and the NO production inhibiting activities of 1-feruloyloxycinnamic acid (<bold>53</bold>) and bisdemethoxycurcumin (<bold>47</bold>) were found. Therefore, the <italic>Z. cassumunar</italic> extract or its constituents have potential applications in the develop natural cosmetic and pharmaceutical products for preventing/treating hypopigmentation, skin aging, or dermatitis.</p></sec><sec id="sec3dot6-molecules-26-02377"><title>3.6. Antifungal and Antibacterial Activities</title><p>The oil of the rhizomes of <italic>Z. cassumunar</italic> was reported to have high antifungal activity (zone of inhibition: 11.7&#x02012;15.7 mm) against five strains of yeasts, <italic>Saccharomyces cerevisiae</italic>, <italic>Cryptococcus neoformans</italic>, <italic>Candida albicans</italic>, <italic>Candida tropicalis,</italic> and <italic>Torulopsis glabrata</italic> [<xref rid="B23-molecules-26-02377" ref-type="bibr">23</xref>]. <italic>Z. cassumunar</italic> oil containing 32 vol % of terpinen-4-ol as its major constituent exhibited antimicrobial activity against a wide range of bacteria (Gram-positive: <italic>Staphylococcus aureus</italic> ATCC 29737, <italic>Streptococcus pyogenes</italic>, <italic>Bacillus subtilis</italic> ATCC6633, <italic>Streptococcus epidermidis</italic> ATCC 12228, and <italic>Propionibacterium acnes</italic>; Gram-negative: <italic>Escherichia coli</italic> ATCC 10536, <italic>Salmonella typhi</italic>, <italic>Pseudomonas aeruginosa</italic> ATCC 25619, <italic>Klebsiella pneumoniae</italic> ATCC 10031, and <italic>Proteus vulgaris</italic>) with minimum bactericidal concentrations ranging from 0.62 to 2.5 vol % [<xref rid="B24-molecules-26-02377" ref-type="bibr">24</xref>]. Antifungal activity against dermatophytes (<italic>Epidermophyton floccosum</italic>, <italic>Microsporum gypseum</italic>, <italic>Trichophyton mentagrophytes</italic>, and <italic>Trichophyton rubrum</italic>) and yeasts (<italic>Candida albicans</italic> and <italic>Cryptococcus neoformans</italic>) by the oil has presented the minimum fungicidal concentration ranging from 0.31 to 0.62 vol %. The hydrodistilled essential oil of cassumunar ginger (<italic>Z. montanum</italic>) containing sabinene, terpinen-4-ol (9.0&#x02013;31.3%), &#x003b3;-terpinene, &#x003b2;-phellandrene, and (<italic>E</italic>)-1-(3&#x02032;,4&#x02032;-dimethoxyphenyl)buta-1,3-diene as major components was evaluated against eight pathogenic bacteria (Gram-positive: <italic>Staphylococcus aureus</italic> (MTCC 96), <italic>Staphylococcus epidermidis</italic> (MTCC 435), and <italic>Streptococcus mutans</italic> (MTCC 890); Gram-negative: <italic>Klebsiella pneumoniae</italic> (MTCC 109), <italic>Pseudomonas aeruginosa</italic> (MTCC 741), <italic>Escherichia coli</italic> (MTCC 723), <italic>Escherichia coli</italic> (DH5<italic>&#x1d6fc;</italic>), and <italic>Salmonella typhimurium</italic> (MTCC 98)) and exhibited good antibacterial activity with minimum inhibitory concentration values ranging from 125 to 500 &#x003bc;g/mL), which is an indication the lowest for <italic>S. typhimurium</italic> [<xref rid="B22-molecules-26-02377" ref-type="bibr">22</xref>]. The oil also showed antifungal activity (250 &#x003bc;g/mL) against two fungal strains (<italic>Candida albicans</italic> (ATCC 14053) and <italic>C. albicans</italic> (MTCC 1637)). The allelopathic activity of the oil on germination and seedling growth of lettuce seed was also demonstrated.</p></sec></sec><sec sec-type="conclusions" id="sec4-molecules-26-02377"><title>4. Conclusions</title><p>This review presented a comprehensive report of the phytochemicals and bioactivities of <italic>Z. cassumunar</italic>. As traditional uses, the rhizomes of this plant have been widely used in different countries in Southeast Asia for the treatment of inflammation, pain, rheumatic arthritis, asthma, and skin trouble. Since 1970s, many studies on the phytochemicals and bioactivity of <italic>Z. cassumunar</italic> have been conducted in order to establish the scientific fundamental facts and evidence of such traditional medicinal uses. Phenylbutenoids and curcuminoids have been mainly isolated from <italic>Z. cassumunar</italic> as a single compound, and its essential oil containing monoterpenoids, sesquiterpenoids, and phenylbutenoids has been assessed primarily for its pharmacological and cosmeceutical use. The extracts, solvent fractions, and constituents of this plant have been discovered to have multiple bioactivities, such as antioxidant, anti-inflammatory (including joint and respiratory inflammation), anticancer, neuroprotective/neurotrophic, and dermatological properties. Therefore, we hope that this review will help to establish experimental design by providing the scientific information for future research and to discover more new medicinal values of <italic>Z. cassumunar</italic>.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, A.-R.H. and E.K.S.; methodology, A.-R.H., C.-H.J. and E.K.S.; software, A.-R.H., H.K. and D.P.; validation A.-R.H. and E.K.S.; formal analysis, A.-R.H., H.K. and D.P.; investigation, A.-R.H., H.K. and D.P.; resources, E.K.S.; data curation, A.-R.H. and C.-H.J.; writing&#x02014;original draft preparation, A.-R.H.; writing&#x02014;review and editing, A.-R.H., C.-H.J. and E.K.S.; visualization, A.-R.H., H.K. and D.P.; supervision, E.K.S.; project administration, A.-R.H. and E.K.S.; funding acquisition, A.-R.H. and E.K.S. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (No. NRF-2021R1A2C1003350) and the Korea Atomic Energy Research Institute (KAERI) grant (No. 523310-21).</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>Not applicable.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-molecules-26-02377"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chongmelaxme</surname><given-names>B.</given-names></name><name><surname>Sruamsiri</surname><given-names>R.</given-names></name><name><surname>Dilokthornsakul</surname><given-names>P.</given-names></name><name><surname>Dhippayom</surname><given-names>T.</given-names></name><name><surname>Kongkaew</surname><given-names>C.</given-names></name><name><surname>Saokaew</surname><given-names>S.</given-names></name><name><surname>Chuthaputti</surname><given-names>A.</given-names></name><name><surname>Chaiyakunapruk</surname><given-names>N.</given-names></name></person-group><article-title>Clinical effects of <italic>Zingiber cassumunar</italic> (Plai): A systematic review</article-title><source>Complement. Ther. Med.</source><year>2017</year><volume>35</volume><fpage>70</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.ctim.2017.09.009</pub-id><?supplied-pmid 29154071?><pub-id pub-id-type="pmid">29154071</pub-id></element-citation></ref><ref id="B2-molecules-26-02377"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>D.M.</given-names></name><name><surname>Nabney</surname><given-names>J.</given-names></name></person-group><article-title>Identification of a novel constituent of the essential oil of <italic>Zingiber cassumunar</italic></article-title><source>Int. Flavors Food Addit.</source><year>1975</year><volume>6</volume><fpage>136</fpage><lpage>137</lpage></element-citation></ref><ref id="B3-molecules-26-02377"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amatayakul</surname><given-names>T.</given-names></name><name><surname>Cannon</surname><given-names>J.R.</given-names></name><name><surname>Dampawan</surname><given-names>P.</given-names></name><name><surname>Dechatiwongse</surname><given-names>T.</given-names></name><name><surname>Giles</surname><given-names>R.G.F.</given-names></name><name><surname>Huntrakul</surname><given-names>C.</given-names></name><name><surname>Kusamran</surname><given-names>K.</given-names></name><name><surname>Mokkhasamit</surname><given-names>M.</given-names></name><name><surname>Raston</surname><given-names>C.L.</given-names></name><name><surname>Reutrakul</surname><given-names>V.</given-names></name><etal/></person-group><article-title>Chemistry and crystal structures of some constituents of <italic>Zingiber cassumunar</italic></article-title><source>Aust. J. Chem.</source><year>1979</year><volume>32</volume><fpage>71</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1071/CH9790071</pub-id></element-citation></ref><ref id="B4-molecules-26-02377"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuroyanagi</surname><given-names>M.</given-names></name><name><surname>Fukushima</surname><given-names>S.</given-names></name><name><surname>Yoshihira</surname><given-names>K.</given-names></name><name><surname>Natori</surname><given-names>S.</given-names></name><name><surname>Dechatiwongse</surname><given-names>T.</given-names></name><name><surname>Mihashi</surname><given-names>K.</given-names></name><name><surname>Nishi</surname><given-names>M.</given-names></name><name><surname>Hara</surname><given-names>S.</given-names></name></person-group><article-title>Further characterization of the constituents of a Thai medicinal plant, <italic>Zingiber cassumunar</italic> ROXB</article-title><source>Chem. Pharm. Bull.</source><year>1980</year><volume>28</volume><fpage>2948</fpage><lpage>2959</lpage><pub-id pub-id-type="doi">10.1248/cpb.28.2948</pub-id></element-citation></ref><ref id="B5-molecules-26-02377"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuntiwachwuttikul</surname><given-names>P.</given-names></name><name><surname>Pancharoen</surname><given-names>O.</given-names></name><name><surname>Jaipetch</surname><given-names>T.</given-names></name><name><surname>Reutrakul</surname><given-names>V.</given-names></name></person-group><article-title>Phenylbutanoids from <italic>Zingiber cassumunar</italic></article-title><source>Phytochemistry</source><year>1981</year><volume>20</volume><fpage>1164</fpage><lpage>1165</lpage><pub-id pub-id-type="doi">10.1016/0031-9422(81)83058-0</pub-id></element-citation></ref><ref id="B6-molecules-26-02377"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jitoe</surname><given-names>A.</given-names></name><name><surname>Masuda</surname><given-names>T.</given-names></name><name><surname>Kato</surname><given-names>N.</given-names></name><name><surname>Nakatani</surname><given-names>N.</given-names></name></person-group><article-title>Phenybutenoid dimers from the rhizomes of <italic>Zingiber cassumunar</italic></article-title><source>Phytochemistry</source><year>1993</year><volume>32</volume><fpage>357</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1016/S0031-9422(00)94994-X</pub-id></element-citation></ref><ref id="B7-molecules-26-02377"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panthong</surname><given-names>A.</given-names></name><name><surname>Kanjanapothi</surname><given-names>D.</given-names></name><name><surname>Niwatananant</surname><given-names>W.</given-names></name><name><surname>Tuntiwachwuttikul</surname><given-names>P.</given-names></name><name><surname>Reutrakul</surname><given-names>V.</given-names></name></person-group><article-title>Anti-inflammatory activity of compound D {(<italic>E</italic>)-4-(3&#x02032;,4&#x02032;-dimethoxyphenyl)but-3-en-2-ol} isolated from <italic>Zingiber cassumunar</italic> Roxb</article-title><source>Phytomedicine</source><year>1997</year><volume>4</volume><fpage>207</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1016/S0944-7113(97)80069-4</pub-id><pub-id pub-id-type="pmid">23195477</pub-id></element-citation></ref><ref id="B8-molecules-26-02377"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>A.R.</given-names></name><name><surname>Min</surname><given-names>H.Y.</given-names></name><name><surname>Windono</surname><given-names>T.</given-names></name><name><surname>Jeohn</surname><given-names>G.H.</given-names></name><name><surname>Jang</surname><given-names>D.S.</given-names></name><name><surname>Lee</surname><given-names>S.K.</given-names></name><name><surname>Seo</surname><given-names>E.K.</given-names></name></person-group><article-title>A new cytotoxic phenylbutenoid dimer from the rhizomes of <italic>Zingiber cassumunar</italic></article-title><source>Planta Med.</source><year>2004</year><volume>70</volume><fpage>1095</fpage><lpage>1097</lpage><pub-id pub-id-type="doi">10.1055/s-2004-832656</pub-id><pub-id pub-id-type="pmid">15549671</pub-id></element-citation></ref><ref id="B9-molecules-26-02377"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>A.R.</given-names></name><name><surname>Kim</surname><given-names>M.S.</given-names></name><name><surname>Jeong</surname><given-names>Y.H.</given-names></name><name><surname>Lee</surname><given-names>S.K.</given-names></name><name><surname>Seo</surname><given-names>E.K.</given-names></name></person-group><article-title>Cyclooxygenase-2 inhibitory phenylbutenoids from the rhizomes of <italic>Zingiber cassumunar</italic></article-title><source>Chem. Pharm. Bull.</source><year>2005</year><volume>53</volume><fpage>1466</fpage><lpage>1468</lpage><pub-id pub-id-type="doi">10.1248/cpb.53.1466</pub-id></element-citation></ref><ref id="B10-molecules-26-02377"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuda</surname><given-names>H.</given-names></name><name><surname>Nakamura</surname><given-names>S.</given-names></name><name><surname>Iwami</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Pongpiriyadacha</surname><given-names>Y.</given-names></name><name><surname>Nakai</surname><given-names>M.</given-names></name><name><surname>Kubo</surname><given-names>M.</given-names></name><name><surname>Fukuyama</surname><given-names>Y.</given-names></name><name><surname>Yoshikawa</surname><given-names>M.</given-names></name></person-group><article-title>Invasion inhibitors of human fibrosarcoma HT 1080 cells from the rhizomes of <italic>Zingiber cassumunar</italic>: Structures of phenylbutanoids, cassumunols</article-title><source>Chem. Pharm. Bull.</source><year>2011</year><volume>59</volume><fpage>365</fpage><lpage>370</lpage><pub-id pub-id-type="doi">10.1248/cpb.59.365</pub-id></element-citation></ref><ref id="B11-molecules-26-02377"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Sun</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Pan</surname><given-names>Y.</given-names></name></person-group><article-title>Preparative isolation and purification of two phenylbutenoids from the rhizomes of <italic>Zingiber cassumunar</italic> by upright counter-current chromatography</article-title><source>J. Chromatogr. A</source><year>2005</year><volume>1089</volume><fpage>258</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1016/j.chroma.2005.06.073</pub-id><pub-id pub-id-type="pmid">16130795</pub-id></element-citation></ref><ref id="B12-molecules-26-02377"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>R.</given-names></name><name><surname>Berthod</surname><given-names>A.</given-names></name><name><surname>Pan</surname><given-names>Y.</given-names></name></person-group><article-title>Rapid screening of bioactive components from <italic>Zingiber cassumunar</italic> using elution-extrusion countercurrent chromatography</article-title><source>J. Chromatogr. A</source><year>2008</year><volume>1181</volume><fpage>33</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/j.chroma.2007.12.055</pub-id><pub-id pub-id-type="pmid">18191870</pub-id></element-citation></ref><ref id="B13-molecules-26-02377"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>S.</given-names></name><name><surname>Iwami</surname><given-names>J.</given-names></name><name><surname>Matsuda</surname><given-names>H.</given-names></name><name><surname>Wakayama</surname><given-names>H.</given-names></name><name><surname>Pongpiriyadacha</surname><given-names>Y.</given-names></name><name><surname>Yoshikawa</surname><given-names>M.</given-names></name></person-group><article-title>Structures of new phenylbutanoids and nitric oxide production inhibitors from the rhizomes of <italic>Zingiber cassumunar</italic></article-title><source>Chem. Pharm. Bull.</source><year>2009</year><volume>57</volume><fpage>1267</fpage><lpage>1272</lpage><pub-id pub-id-type="doi">10.1248/cpb.57.1267</pub-id></element-citation></ref><ref id="B14-molecules-26-02377"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kubo</surname><given-names>M.</given-names></name><name><surname>Gima</surname><given-names>M.</given-names></name><name><surname>Baba</surname><given-names>K.</given-names></name><name><surname>Nakai</surname><given-names>M.</given-names></name><name><surname>Harada</surname><given-names>K.</given-names></name><name><surname>Suenaga</surname><given-names>M.</given-names></name><name><surname>Matsunaga</surname><given-names>Y.</given-names></name><name><surname>Kato</surname><given-names>E.</given-names></name><name><surname>Hosoda</surname><given-names>S.</given-names></name><name><surname>Fukuyama</surname><given-names>Y.</given-names></name></person-group><article-title>Novel neurotrophic phenylbutenoids from Indonesian ginger Bangle, <italic>Zingiber purpureum</italic></article-title><source>Bioorg. Med. Chem. Lett.</source><year>2015</year><volume>25</volume><fpage>1586</fpage><lpage>1591</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2015.02.005</pub-id><pub-id pub-id-type="pmid">25728129</pub-id></element-citation></ref><ref id="B15-molecules-26-02377"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>A.-R.</given-names></name><name><surname>Lee</surname><given-names>E.-J.</given-names></name><name><surname>Min</surname><given-names>H.-Y.</given-names></name><name><surname>Kim</surname><given-names>H.-R.</given-names></name><name><surname>Lee</surname><given-names>S.K.</given-names></name><name><surname>Seo</surname><given-names>E.-K.</given-names></name></person-group><article-title>A potential cytotoxic principle of <italic>Zingiber cassumunar</italic></article-title><source>Nat. Prod. Sci.</source><year>2003</year><volume>9</volume><fpage>109</fpage><lpage>111</lpage></element-citation></ref><ref id="B16-molecules-26-02377"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jitoe</surname><given-names>A.</given-names></name><name><surname>Masuda</surname><given-names>T.</given-names></name><name><surname>Mabry</surname><given-names>T.J.</given-names></name></person-group><article-title>Novel antioxidants, cassumunarin A, B, C, from <italic>Zingiber cassumunar</italic></article-title><source>Tetrahedron Lett.</source><year>1994</year><volume>35</volume><fpage>981</fpage><lpage>984</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(00)79944-8</pub-id></element-citation></ref><ref id="B17-molecules-26-02377"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>M.-X.</given-names></name><name><surname>Bai</surname><given-names>X.</given-names></name><name><surname>Ma</surname><given-names>Y.-P.</given-names></name><name><surname>Zhang</surname><given-names>H.-X.</given-names></name><name><surname>Nama</surname><given-names>N.</given-names></name><name><surname>Pei</surname><given-names>S.-J.</given-names></name><name><surname>Du</surname><given-names>Z.-Z.</given-names></name></person-group><article-title>Cosmetic potentials of extracts and compounds from <italic>Zingiber cassumunar</italic> Roxb. rhizome</article-title><source>Ind. Crops Prod.</source><year>2019</year><volume>141</volume><fpage>111764</fpage><pub-id pub-id-type="doi">10.1016/j.indcrop.2019.111764</pub-id></element-citation></ref><ref id="B18-molecules-26-02377"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dinter</surname><given-names>H.</given-names></name><name><surname>Haensel</surname><given-names>R.</given-names></name><name><surname>Pelter</surname><given-names>A.</given-names></name></person-group><article-title>The structures of cassumunaquinones 1 and 2 from <italic>Zingiber cassumunar</italic></article-title><source>Z Naturforsch. C</source><year>1980</year><volume>35C</volume><fpage>154</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1515/znc-1980-1-229</pub-id></element-citation></ref><ref id="B19-molecules-26-02377"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kongsui</surname><given-names>R.</given-names></name><name><surname>Sriraksa</surname><given-names>N.</given-names></name><name><surname>Thongrong</surname><given-names>S.</given-names></name></person-group><article-title>The neuroprotective effect of <italic>Zingiber cassumunar</italic> Roxb. extract on LPS-induced neuronal cell loss and astroglial activation within the hippocampus</article-title><source>BioMed Res. Int</source><year>2020</year><volume>2020</volume><fpage>4259316</fpage><pub-id pub-id-type="doi">10.1155/2020/4259316</pub-id><pub-id pub-id-type="pmid">32596307</pub-id></element-citation></ref><ref id="B20-molecules-26-02377"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsui</surname><given-names>N.</given-names></name><name><surname>Kido</surname><given-names>Y.</given-names></name><name><surname>Okada</surname><given-names>H.</given-names></name><name><surname>Kubo</surname><given-names>M.</given-names></name><name><surname>Nakai</surname><given-names>M.</given-names></name><name><surname>Fukuishi</surname><given-names>N.</given-names></name><name><surname>Fukuyama</surname><given-names>Y.</given-names></name><name><surname>Akagi</surname><given-names>M.</given-names></name></person-group><article-title>Phenylbutenoid dimers isolated from <italic>Zingiber purpureum</italic> exert neurotrophic effects on cultured neurons and enhance hippocampal neurogenesis in olfactory bulbectomized mice</article-title><source>Neurosci. Lett.</source><year>2012</year><volume>513</volume><fpage>72</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2012.02.010</pub-id><pub-id pub-id-type="pmid">22343027</pub-id></element-citation></ref><ref id="B21-molecules-26-02377"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>J.</given-names></name><name><surname>Chung</surname><given-names>H.</given-names></name><name><surname>Hyun</surname><given-names>B.S.</given-names></name><name><surname>Han</surname><given-names>A.-R.</given-names></name><name><surname>Seo</surname><given-names>E.K.</given-names></name><name><surname>Eun</surname><given-names>C.S.</given-names></name><name><surname>Kang</surname><given-names>D.-H.</given-names></name><name><surname>Oh</surname><given-names>E.-S.</given-names></name></person-group><article-title>(<italic>E</italic>)-4-(3,4-dimethoxyphenyl)but-3-en-1-ol enhances melanogenesis through increasing upstream stimulating factor-1-mediated tyrosinase expression</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><elocation-id>e0141988</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0141988</pub-id><pub-id pub-id-type="pmid">26535571</pub-id></element-citation></ref><ref id="B22-molecules-26-02377"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>R.S.</given-names></name><name><surname>Joshi</surname><given-names>N.</given-names></name><name><surname>Padalia</surname><given-names>R.C.</given-names></name><name><surname>Singh</surname><given-names>V.R.</given-names></name><name><surname>Goswami</surname><given-names>P.</given-names></name><name><surname>Verma</surname><given-names>S.K.</given-names></name><name><surname>Iqbal</surname><given-names>H.</given-names></name><name><surname>Chanda</surname><given-names>D.</given-names></name><name><surname>Verma</surname><given-names>R.K.</given-names></name><name><surname>Darokar</surname><given-names>M.P.</given-names></name><etal/></person-group><article-title>Chemical composition and antibacterial, antifungal, allelopathic and acetylcholinesterase inhibitory activities of cassumunar-ginger</article-title><source>J. Sci. Food Agric.</source><year>2018</year><volume>98</volume><fpage>321</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1002/jsfa.8474</pub-id><pub-id pub-id-type="pmid">28585369</pub-id></element-citation></ref><ref id="B23-molecules-26-02377"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bin Jantan</surname><given-names>I.</given-names></name><name><surname>Yassin</surname><given-names>M.S.M.</given-names></name><name><surname>Chin</surname><given-names>C.B.</given-names></name><name><surname>Chen</surname><given-names>L.L.</given-names></name><name><surname>Sim</surname><given-names>N.L.</given-names></name></person-group><article-title>Antifungal activity of the essential oils of nine Zingiberaceae species</article-title><source>Pharm. Biol.</source><year>2003</year><volume>41</volume><fpage>392</fpage><lpage>397</lpage><pub-id pub-id-type="doi">10.1076/phbi.41.5.392.15941</pub-id></element-citation></ref><ref id="B24-molecules-26-02377"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pithayanukul</surname><given-names>P.</given-names></name><name><surname>Tubprasert</surname><given-names>J.</given-names></name><name><surname>Wuthi-Udomlert</surname><given-names>M.</given-names></name></person-group><article-title>In vitro antimicrobial activity of <italic>Zingiber cassumunar</italic> (Plai) oil and a 5% Plai oil gel</article-title><source>Phytother. Res.</source><year>2007</year><volume>21</volume><fpage>164</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1002/ptr.2048</pub-id><pub-id pub-id-type="pmid">17128430</pub-id></element-citation></ref><ref id="B25-molecules-26-02377"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>G.</given-names></name><name><surname>Lee</surname><given-names>E.-J.</given-names></name><name><surname>Min</surname><given-names>H.-Y.</given-names></name><name><surname>Choi</surname><given-names>H.-Y.</given-names></name><name><surname>Han</surname><given-names>A.-R.</given-names></name><name><surname>Lee</surname><given-names>S.K.</given-names></name><name><surname>Seo</surname><given-names>E.K.</given-names></name></person-group><article-title>Evaluation of cytotoxic potential of Indonesian medicinal plants in cultured human cancer cells</article-title><source>Nat. Prod. Sci.</source><year>2002</year><volume>8</volume><fpage>165</fpage><lpage>169</lpage></element-citation></ref><ref id="B26-molecules-26-02377"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.-W.</given-names></name><name><surname>Min</surname><given-names>H.Y.</given-names></name><name><surname>Han</surname><given-names>A.-R.</given-names></name><name><surname>Chung</surname><given-names>H.-J.</given-names></name><name><surname>Park</surname><given-names>E.J.</given-names></name><name><surname>Park</surname><given-names>H.J.</given-names></name><name><surname>Hong</surname><given-names>J.Y.</given-names></name><name><surname>Seo</surname><given-names>E.-K.</given-names></name><name><surname>Lee</surname><given-names>S.K.</given-names></name></person-group><article-title>Growth inhibition and induction of G1 phase cell cycle arrest in human lung cancer cells by a phenylbutenoid dimer isolated from <italic>Zingiber cassumunar</italic></article-title><source>Biol. Pharm. Bull.</source><year>2007</year><volume>30</volume><fpage>1561</fpage><lpage>1564</lpage><pub-id pub-id-type="doi">10.1248/bpb.30.1561</pub-id><pub-id pub-id-type="pmid">17666821</pub-id></element-citation></ref><ref id="B27-molecules-26-02377"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Go</surname><given-names>E.J.</given-names></name><name><surname>Kim</surname><given-names>H.R.</given-names></name><name><surname>Chung</surname><given-names>S.Y.</given-names></name><name><surname>Jeong</surname><given-names>Y.H.</given-names></name><name><surname>Kim</surname><given-names>N.H.</given-names></name><name><surname>Han</surname><given-names>A.-R.</given-names></name><name><surname>Seo</surname><given-names>E.-K.</given-names></name><name><surname>Lee</surname><given-names>H.J.</given-names></name></person-group><article-title>Evaluation of the P-glycoprotein inhibitory activity of Indonesian medicinal plants</article-title><source>Nat. Prod. Sci.</source><year>2004</year><volume>10</volume><fpage>85</fpage><lpage>88</lpage></element-citation></ref><ref id="B28-molecules-26-02377"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H.R.</given-names></name><name><surname>Chung</surname><given-names>S.Y.</given-names></name><name><surname>Jeong</surname><given-names>Y.H.</given-names></name><name><surname>Eun Jung</surname><given-names>H.</given-names></name><name><surname>Ah-Reum</surname><given-names>K.</given-names></name><name><surname>Na Hyung</surname><given-names>M.</given-names></name><name><surname>KyungSung</surname><given-names>S.</given-names></name><name><surname>Gina</surname><given-names>J.</given-names></name><name><surname>Ok</surname><given-names>J.</given-names></name><name><surname>Nam</surname><given-names>J.W.</given-names></name><etal/></person-group><article-title>P-glycoprotein inhibitory activity of Indonesian medicinal plants in human breast cancer cells</article-title><source>Nat. Prod. Sci.</source><year>2004</year><volume>10</volume><fpage>268</fpage><lpage>271</lpage></element-citation></ref><ref id="B29-molecules-26-02377"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>S.Y.</given-names></name><name><surname>Han</surname><given-names>A.-R.</given-names></name><name><surname>Sung</surname><given-names>M.K.</given-names></name><name><surname>Jung</surname><given-names>H.J.</given-names></name><name><surname>Nam</surname><given-names>J.W.</given-names></name><name><surname>Seo</surname><given-names>E.-K.</given-names></name><name><surname>Lee</surname><given-names>H.J.</given-names></name></person-group><article-title>Potent modulation of P-glycoprotein activity by naturally occurring phenylbutenoids from <italic>Zingiber Cassumunar</italic></article-title><source>Phytother. Res.</source><year>2009</year><volume>23</volume><fpage>472</fpage><lpage>476</lpage><pub-id pub-id-type="doi">10.1002/ptr.2650</pub-id><?supplied-pmid 19051210?><pub-id pub-id-type="pmid">19051210</pub-id></element-citation></ref><ref id="B30-molecules-26-02377"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>J.</given-names></name><name><surname>Suh</surname><given-names>D.H.</given-names></name><name><surname>Lee</surname><given-names>G.</given-names></name><name><surname>Han</surname><given-names>A.R.</given-names></name><name><surname>Chae</surname><given-names>S.W.</given-names></name><name><surname>Lee</surname><given-names>H.J.</given-names></name><name><surname>Seo</surname><given-names>E.K.</given-names></name><name><surname>Lim</surname><given-names>H.J.</given-names></name></person-group><article-title>Synthesis and biological activity of optically active phenylbutenoid dimers</article-title><source>J. Nat. Prod.</source><year>2011</year><volume>74</volume><fpage>1817</fpage><lpage>1821</lpage><pub-id pub-id-type="doi">10.1021/np100942e</pub-id><?supplied-pmid 21770432?><pub-id pub-id-type="pmid">21770432</pub-id></element-citation></ref><ref id="B31-molecules-26-02377"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chae</surname><given-names>S.W.</given-names></name><name><surname>Han</surname><given-names>A.R.</given-names></name><name><surname>Park</surname><given-names>J.H.</given-names></name><name><surname>Rhie</surname><given-names>J.Y.</given-names></name><name><surname>Lim</surname><given-names>H.J.</given-names></name><name><surname>Seo</surname><given-names>E.K.</given-names></name><name><surname>Lee</surname><given-names>H.J.</given-names></name></person-group><article-title>In vitro and in vivo evaluation of phenylbutenoid dimers as inhibitors of P-glycoprotein</article-title><source>J. Nat. Prod.</source><year>2013</year><volume>76</volume><fpage>2277</fpage><lpage>2281</lpage><pub-id pub-id-type="doi">10.1021/np4004917</pub-id><?supplied-pmid 24266329?><pub-id pub-id-type="pmid">24266329</pub-id></element-citation></ref><ref id="B32-molecules-26-02377"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.-J.</given-names></name><name><surname>Kim</surname><given-names>H.S.</given-names></name><name><surname>Lee</surname><given-names>J.S.</given-names></name><name><surname>Park</surname><given-names>J.</given-names></name><name><surname>Shin</surname><given-names>S.C.</given-names></name><name><surname>Song</surname><given-names>S.</given-names></name><name><surname>Lee</surname><given-names>E.</given-names></name><name><surname>Choi</surname><given-names>J.E.</given-names></name><name><surname>Suh</surname><given-names>J.-W.</given-names></name><name><surname>Lee</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Small molecule activator of Nm23/NDPK as an inhibitor of metastasis</article-title><source>Sci. Rep.</source><year>2018</year><volume>8</volume><fpage>10909</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-29101-6</pub-id><pub-id pub-id-type="pmid">30026594</pub-id></element-citation></ref><ref id="B33-molecules-26-02377"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabulal</surname><given-names>B.</given-names></name><name><surname>Dan</surname><given-names>M.</given-names></name><name><surname>Kurup</surname><given-names>R.</given-names></name><name><surname>Chandrika</surname><given-names>S.P.</given-names></name><name><surname>George</surname><given-names>V.</given-names></name></person-group><article-title>Phenylbutanoid-rich rhizome oil of <italic>Zingiber neesanum</italic> from Western Ghats, southern India</article-title><source>Flavour Fragr. J.</source><year>2007</year><volume>22</volume><fpage>521</fpage><lpage>524</lpage><pub-id pub-id-type="doi">10.1002/ffj.1834</pub-id></element-citation></ref><ref id="B34-molecules-26-02377"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masuda</surname><given-names>T.</given-names></name><name><surname>Andoh</surname><given-names>T.</given-names></name><name><surname>Yonemori</surname><given-names>S.</given-names></name><name><surname>Takeda</surname><given-names>Y.</given-names></name></person-group><article-title>Phenylbutenoids from the rhizomes of <italic>Alpinia flabellate</italic></article-title><source>Phytochemistry</source><year>1998</year><volume>50</volume><fpage>163</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1016/S0031-9422(98)00457-9</pub-id></element-citation></ref><ref id="B35-molecules-26-02377"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>D.-D.</given-names></name><name><surname>Zhao</surname><given-names>Q.-S.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>Z.Q.</given-names></name><name><surname>Zeng</surname><given-names>W.-M.</given-names></name><name><surname>Lei</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>Y.-L.</given-names></name></person-group><article-title>Compounds from <italic>Dryopteris fragrans</italic> (L.) Schott with cytotoxic activity</article-title><source>Molecules</source><year>2014</year><volume>19</volume><fpage>3345</fpage><lpage>3355</lpage><pub-id pub-id-type="doi">10.3390/molecules19033345</pub-id><pub-id pub-id-type="pmid">24647035</pub-id></element-citation></ref><ref id="B36-molecules-26-02377"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Lin</surname><given-names>L.</given-names></name><name><surname>Sun</surname><given-names>Z.</given-names></name><name><surname>Sun</surname><given-names>C.</given-names></name><name><surname>Pan</surname><given-names>Y.</given-names></name></person-group><article-title>Differentiation of configurations of the phenylbutenoid dimer derivatives from <italic>Zingiber cassumunar</italic> by tandem mass spectrometry</article-title><source>Rapid Commun. Mass Spectrom.</source><year>2009</year><volume>23</volume><fpage>1654</fpage><lpage>1658</lpage><pub-id pub-id-type="doi">10.1002/rcm.4050</pub-id><pub-id pub-id-type="pmid">19408345</pub-id></element-citation></ref><ref id="B37-molecules-26-02377"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kishore</surname><given-names>N.</given-names></name><name><surname>Dwivedi</surname><given-names>R.S.</given-names></name></person-group><article-title>Zerumbone: A potential fungitoxic agent isolated from <italic>Zingiber cassumunar</italic> Roxb</article-title><source>Mycopathologia</source><year>1992</year><volume>120</volume><fpage>155</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1007/BF00436393</pub-id></element-citation></ref><ref id="B38-molecules-26-02377"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leelarungrayub</surname><given-names>D.</given-names></name><name><surname>Suttajit</surname><given-names>M.</given-names></name></person-group><article-title>Potential antioxidant and anti-inflammatory activities of Thai plai (<italic>Zingiber cassumunar</italic> Roxb.) essential oil</article-title><source>Int. J. Essent. Oil Ther.</source><year>2009</year><volume>3</volume><fpage>25</fpage><lpage>30</lpage></element-citation></ref><ref id="B39-molecules-26-02377"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mektrirat</surname><given-names>R.</given-names></name><name><surname>Yano</surname><given-names>T.</given-names></name><name><surname>Okonogi</surname><given-names>S.</given-names></name><name><surname>Katip</surname><given-names>W.</given-names></name><name><surname>Pikulkaew</surname><given-names>S.</given-names></name></person-group><article-title>Phytochemical and safety evaluations of volatile terpenoids from <italic>Zingiber cassumunar</italic> Roxb. On mature carp peripheral blood mononuclear cells and embryonic zebrafish</article-title><source>Molecules</source><year>2020</year><volume>25</volume><elocation-id>613</elocation-id><pub-id pub-id-type="doi">10.3390/molecules25030613</pub-id></element-citation></ref><ref id="B40-molecules-26-02377"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pongprayoon</surname><given-names>U.</given-names></name><name><surname>Soontornsaratune</surname><given-names>P.</given-names></name><name><surname>Jarikasem</surname><given-names>S.</given-names></name><name><surname>Sematong</surname><given-names>T.</given-names></name><name><surname>Wasuwat</surname><given-names>S.</given-names></name><name><surname>Claeson</surname><given-names>P.</given-names></name></person-group><article-title>Topical antiinflammatory activity of the major lipophilic constituents of the rhizome of <italic>Zingiber cassumunar</italic>. Part 1. The essential oil</article-title><source>Phytomedicine</source><year>1997</year><volume>3</volume><fpage>319</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1016/S0944-7113(97)80003-7</pub-id><pub-id pub-id-type="pmid">23195188</pub-id></element-citation></ref><ref id="B41-molecules-26-02377"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brophy</surname><given-names>T.J.J.</given-names></name><name><surname>Zwaving</surname><given-names>J.H.</given-names></name></person-group><article-title>Analysis of the essential oil of <italic>Zingiber cassumunar</italic> Roxb. from Indonesia</article-title><source>Flavour Fragr. J.</source><year>1991</year><volume>6</volume><fpage>161</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1002/ffj.2730060214</pub-id></element-citation></ref><ref id="B42-molecules-26-02377"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagano</surname><given-names>T.</given-names></name><name><surname>Oyama</surname><given-names>Y.</given-names></name><name><surname>Kajita</surname><given-names>N.</given-names></name><name><surname>Chikahisa</surname><given-names>L.</given-names></name><name><surname>Nakata</surname><given-names>M.</given-names></name><name><surname>Okazaki</surname><given-names>E.</given-names></name><name><surname>Masuda</surname><given-names>T.</given-names></name></person-group><article-title>New curcuminoids isolated from <italic>Zingiber cassumunar</italic> protect cells suffering from oxidative stress: A flow-cytometric study using rat thymocytes and H<sub>2</sub>O<sub>2</sub></article-title><source>Jpn. J. Pharmacol.</source><year>1997</year><volume>75</volume><fpage>363</fpage><lpage>370</lpage><pub-id pub-id-type="doi">10.1254/jjp.75.363</pub-id><?supplied-pmid 9469642?><pub-id pub-id-type="pmid">9469642</pub-id></element-citation></ref><ref id="B43-molecules-26-02377"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Indrianingsih</surname><given-names>A.W.</given-names></name><name><surname>Prihantini</surname><given-names>A.</given-names></name></person-group><article-title>Indah. In vitro antioxidant and &#x003b1;-glucosidase inhibitory assay of <italic>Zingiber cassumunar</italic> roxb</article-title><source>AIP Conf. Proc.</source><year>2018</year><volume>2026</volume><fpage>020005</fpage></element-citation></ref><ref id="B44-molecules-26-02377"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sari</surname><given-names>N.</given-names></name></person-group><article-title>Nurkhasanah; Sulistyani, Nanik. The antioxidant effect of bangle (<italic>Zingiber cassumunar</italic>) rhizome extract on superoxide dismutase (sod) activity in hyperlipidemic rats</article-title><source>Res. J. Chem Environ.</source><year>2020</year><volume>24</volume><fpage>78</fpage><lpage>81</lpage></element-citation></ref><ref id="B45-molecules-26-02377"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaewchoothong</surname><given-names>A.</given-names></name><name><surname>Tewtrakul</surname><given-names>S.</given-names></name><name><surname>Panichayupakaranant</surname><given-names>P.</given-names></name></person-group><article-title>Inhibitory effect of phenylbutanoid-rich <italic>Zingiber cassumunar</italic> extracts on nitric oxide production by murine macrophage-like RAW264.7 cells</article-title><source>Phytother. Res.</source><year>2012</year><volume>26</volume><fpage>1789</fpage><lpage>1792</lpage><pub-id pub-id-type="doi">10.1002/ptr.4661</pub-id><pub-id pub-id-type="pmid">22389026</pub-id></element-citation></ref><ref id="B46-molecules-26-02377"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozaki</surname><given-names>Y.</given-names></name><name><surname>Kawahara</surname><given-names>N.</given-names></name><name><surname>Harada</surname><given-names>M.</given-names></name></person-group><article-title>Anti-inflammatory effect of <italic>Zingiber cassumunar</italic> Roxb. and its active principles</article-title><source>Chem. Pharm. Bull.</source><year>1991</year><volume>39</volume><fpage>2353</fpage><lpage>2356</lpage><pub-id pub-id-type="doi">10.1248/cpb.39.2353</pub-id><?supplied-pmid 1804548?><pub-id pub-id-type="pmid">1804548</pub-id></element-citation></ref><ref id="B47-molecules-26-02377"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Limvuttegrijerat</surname><given-names>T.</given-names></name><name><surname>Poachanukoon</surname><given-names>O.</given-names></name><name><surname>Koontongkaew</surname><given-names>S.</given-names></name><name><surname>Na Ayudhya</surname><given-names>T.D.</given-names></name></person-group><article-title>Crude ethanolic extracts of <italic>Zingiber cassumunar</italic> ROXB. inhibit PMA-induced MUC2 and MUC5AC expression via ERK inhibition in human airway epithelial cells</article-title><source>Asian Pac. J. Allergy Immunol.</source><year>2014</year><volume>32</volume><fpage>328</fpage><lpage>336</lpage><pub-id pub-id-type="pmid">25543044</pub-id></element-citation></ref><ref id="B48-molecules-26-02377"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pongprayoon</surname><given-names>U.</given-names></name><name><surname>Tuchinda</surname><given-names>P.</given-names></name><name><surname>Claeson</surname><given-names>P.</given-names></name><name><surname>Sematong</surname><given-names>T.</given-names></name><name><surname>Reutrakul</surname><given-names>V.</given-names></name><name><surname>Soontornsaratune</surname><given-names>P.</given-names></name></person-group><article-title>Topical antiinflammatory activity of the major lipophilic constituents of the rhizome of <italic>Zingiber cassumunar</italic>. Part 2. Hexane extractives</article-title><source>Phytomedicine</source><year>1997</year><volume>3</volume><fpage>323</fpage><lpage>326</lpage><pub-id pub-id-type="doi">10.1016/S0944-7113(97)80004-9</pub-id><pub-id pub-id-type="pmid">23195189</pub-id></element-citation></ref><ref id="B49-molecules-26-02377"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aupaphong</surname><given-names>V.</given-names></name><name><surname>Dechatiwongse Na Ayudhya</surname><given-names>T.</given-names></name><name><surname>Koontongkaew</surname><given-names>S.</given-names></name></person-group><article-title>Inhibition of lipopolysaccharide-induced expression of cyclooxygenase-2 by <italic>Zingiber cassumunar</italic> Roxb. constituents in human dental pulp cells</article-title><source>J. Med. Plants Res.</source><year>2013</year><volume>7</volume><fpage>2451</fpage><lpage>2458</lpage></element-citation></ref><ref id="B50-molecules-26-02377"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rujirek</surname><given-names>C.</given-names></name><name><surname>Siriwan</surname><given-names>O.</given-names></name><name><surname>Siriwan</surname><given-names>T.</given-names></name><name><surname>Prachya</surname><given-names>K.</given-names></name><name><surname>Ampai</surname><given-names>P.</given-names></name><name><surname>Vichai</surname><given-names>R.</given-names></name></person-group><article-title>Chondroprotective potential of bioactive compounds of <italic>Zingiber cassumunar</italic> Roxb. against cytokineinduced cartilage degradation in explant culture</article-title><source>J. Med. Plants Res.</source><year>2012</year><volume>6</volume><fpage>5204</fpage><lpage>5213</lpage><pub-id pub-id-type="doi">10.5897/JMPR11.1633</pub-id></element-citation></ref><ref id="B51-molecules-26-02377"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaiwongsa</surname><given-names>R.</given-names></name><name><surname>Ongchai</surname><given-names>S.</given-names></name><name><surname>Boonsing</surname><given-names>P.</given-names></name><name><surname>Kongtawelert</surname><given-names>P.</given-names></name><name><surname>Panthong</surname><given-names>A.</given-names></name><name><surname>Reutrakul</surname><given-names>V.</given-names></name></person-group><article-title>Active compound of <italic>Zingiber cassumunar</italic> Roxb. down-regulates the expression of genes involved in joint erosion in a human synovial fibroblast cell line</article-title><source>Afr. J. Trad. Complement. Altern. Med.</source><year>2013</year><volume>10</volume><fpage>40</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.4314/ajtcam.v10i1.7</pub-id><?supplied-pmid 24082324?><pub-id pub-id-type="pmid">24082324</pub-id></element-citation></ref><ref id="B52-molecules-26-02377"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poachanukoon</surname><given-names>O.</given-names></name><name><surname>Meesuk</surname><given-names>L.</given-names></name><name><surname>Pattanacharoenchai</surname><given-names>N.</given-names></name><name><surname>Monthanapisut</surname><given-names>P.</given-names></name><name><surname>Dechatiwongse Na Ayudhya</surname><given-names>T.</given-names></name><name><surname>Koontongkaew</surname><given-names>S.</given-names></name></person-group><article-title>Zingiber cassumunar ROXb. and its active constituent inhibit MMP-9 direct activation by house dust mite allergens and MMP-9 expression in PMA-stimulated human airway epithelial cells</article-title><source>Asian Pac. J. Allergy Immunol.</source><year>2015</year><volume>33</volume><fpage>42</fpage><lpage>51</lpage><?supplied-pmid 25840633?><pub-id pub-id-type="pmid">25840633</pub-id></element-citation></ref><ref id="B53-molecules-26-02377"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jitapunkul</surname><given-names>K.</given-names></name><name><surname>Poachanukoon</surname><given-names>O.</given-names></name><name><surname>Hannongbua</surname><given-names>S.</given-names></name><name><surname>Toochinda</surname><given-names>P.</given-names></name><name><surname>Lawtrakul</surname><given-names>L.</given-names></name></person-group><article-title>Simulation Study of Interactions between two bioactive components from <italic>Zingiber cassumunar</italic> and 5-lipoxygenase</article-title><source>Cell Mol. Bioeng.</source><year>2018</year><volume>11</volume><fpage>77</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1007/s12195-017-0515-6</pub-id><pub-id pub-id-type="pmid">31719880</pub-id></element-citation></ref><ref id="B54-molecules-26-02377"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anasamy</surname><given-names>T.</given-names></name><name><surname>Abdul</surname><given-names>A.B.</given-names></name><name><surname>Sukari</surname><given-names>M.A.</given-names></name><name><surname>Abdelwahab</surname><given-names>S.I.</given-names></name><name><surname>Mohan</surname><given-names>S.</given-names></name><name><surname>Kamalidehghan</surname><given-names>B.</given-names></name><name><surname>Azid</surname><given-names>M.Z.</given-names></name><name><surname>Muhammad Nadzri</surname><given-names>N.</given-names></name><name><surname>Andas</surname><given-names>A.R.J.</given-names></name><name><surname>Kuan Beng</surname><given-names>N.</given-names></name><etal/></person-group><article-title>A Phenylbutenoid dimer, <italic>cis</italic>-3-(3&#x02032;,4&#x02032;-dimethoxyphenyl)-4-[(<italic>E</italic>)-3&#x02032;&#x02032;&#x02032;,4&#x02032;&#x02032;&#x02032;-dimethoxystyryl]cyclohex-1-ene, exhibits apoptogenic properties in T-acute lymphoblastic leukemia cells via induction of p53-independent mitochondrial signalling pathway</article-title><source>Evid. Based Complement. Alternat. Med.</source><year>2013</year><volume>2013</volume><fpage>939810</fpage><pub-id pub-id-type="doi">10.1155/2013/939810</pub-id><?supplied-pmid 23710242?><pub-id pub-id-type="pmid">23710242</pub-id></element-citation></ref><ref id="B55-molecules-26-02377"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeenapongsa</surname><given-names>R.</given-names></name><name><surname>Yoovathaworn</surname><given-names>K.</given-names></name><name><surname>Sriwatanakul</surname><given-names>K.M.</given-names></name><name><surname>Pongprayoon</surname><given-names>U.</given-names></name><name><surname>Sriwatanakul</surname><given-names>K.</given-names></name></person-group><article-title>Anti-inflammatory activity of (<italic>E</italic>)-1-(3,4-dimethoxyphenyl) butadiene from <italic>Zingiber cassumunar</italic> Roxb</article-title><source>J. Ethnopharmacol.</source><year>2003</year><volume>87</volume><fpage>143</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(03)00098-9</pub-id><pub-id pub-id-type="pmid">12860299</pub-id></element-citation></ref><ref id="B56-molecules-26-02377"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koysooko</surname><given-names>R.</given-names></name><name><surname>Varavudhi</surname><given-names>P.</given-names></name><name><surname>Pinthong</surname><given-names>T.</given-names></name><name><surname>Wattanapermpool</surname><given-names>J.</given-names></name></person-group><article-title>Development of <italic>Zingiber cassumunar</italic> for asthmatic treatment: Pharmacokinetics in animals</article-title><source>J. Sci. Soc. Thai.</source><year>1988</year><volume>14</volume><fpage>197</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.2306/scienceasia1513-1874.1988.14.197</pub-id></element-citation></ref><ref id="B57-molecules-26-02377"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khemawoot</surname><given-names>P.</given-names></name><name><surname>Hunsakunachai</surname><given-names>N.</given-names></name><name><surname>Anukunwithaya</surname><given-names>T.</given-names></name><name><surname>Bangphumi</surname><given-names>K.</given-names></name><name><surname>Ongpipattanakul</surname><given-names>B.</given-names></name><name><surname>Jiratchariyakul</surname><given-names>W.</given-names></name><name><surname>Soawakontha</surname><given-names>R.</given-names></name><name><surname>Inthachart</surname><given-names>T.</given-names></name><name><surname>Dechatiwongse Na Ayudhya</surname><given-names>T.</given-names></name><name><surname>Koontongkaew</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Pharmacokinetics of compound D, the major bioactive component of <italic>Zingiber cassumunar</italic>, in rats</article-title><source>Planta Med.</source><year>2016</year><volume>82</volume><fpage>1186</fpage><lpage>1191</lpage><pub-id pub-id-type="doi">10.1055/s-0042-104658</pub-id><pub-id pub-id-type="pmid">27124244</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="molecules-26-02377-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Photograph of a sample of <italic>Z. cassumunar</italic> collected from Surabaya, Indonesia, in 2001, which was identified by Professor Tri Windono (University of Surabaya, Indonesia).</p></caption><graphic xlink:href="molecules-26-02377-g001"/></fig><fig id="molecules-26-02377-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Structures of phenylbutenoids isolated from <italic>Z. cassumunar</italic>.</p></caption><graphic xlink:href="molecules-26-02377-g002"/></fig><fig id="molecules-26-02377-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Structures of other compounds isolated from <italic>Z. cassumunar</italic>. Curcuminoids, <bold>42</bold>&#x02013;<bold>47</bold>; quinones, <bold>48</bold> and <bold>49</bold>; phenolic compounds, <bold>50</bold>&#x02013;<bold>53</bold>; sesquiterpenoids, <bold>54</bold>&#x02013;<bold>57</bold>; and monoterpenoids, <bold>58</bold>&#x02013;<bold>61</bold>.</p></caption><graphic xlink:href="molecules-26-02377-g003"/></fig><table-wrap id="molecules-26-02377-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-26-02377-t001_Table 1</object-id><label>Table 1</label><caption><p>Bioactivities of extracts, fractions, and constituents of <italic>Z. cassumunar</italic>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Extracts, Fractions, or Compounds</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Bioactivities</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cell Lines or Models</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td rowspan="9" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Essential oil</td><td rowspan="2" align="center" valign="middle" colspan="1">Antioxidant</td><td align="center" valign="middle" rowspan="1" colspan="1">ABTS scavenging activity; H<sub>2</sub>O<sub>2</sub> scavenging activity in U937 cells</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B38-molecules-26-02377" ref-type="bibr">38</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">SOD enzyme activity in rat induced by HFD</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B44-molecules-26-02377" ref-type="bibr">44</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" rowspan="1" colspan="1">Carrageenin-induced hind-paw edema test in rats</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B40-molecules-26-02377" ref-type="bibr">40</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">LPS-induced NO production in RAW264.7 cells</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B45-molecules-26-02377" ref-type="bibr">45</xref>]</td></tr><tr><td rowspan="3" align="center" valign="middle" colspan="1">Antifungal</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Saccharomyces cerevisiae</italic>, <italic>Cryptococcus neoformans</italic>, <italic>Candida albicans</italic>, <italic>Candida tropicalis</italic>, and <italic>Torulopsis glabrata</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B23-molecules-26-02377" ref-type="bibr">23</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Epidermophyton floccosum</italic>, <italic>Microsporum gypseum</italic>, <italic>Trichophyton mentagrophytes</italic>, <italic>Trichophyton rubrum</italic>, <italic>Candida albicans</italic>, and <italic>Cryptococcus neoformans</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B24-molecules-26-02377" ref-type="bibr">24</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Candida albicans</italic> (ATCC 14053) and <italic>C. albicans</italic> (MTCC 1637)</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B22-molecules-26-02377" ref-type="bibr">22</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Antimicrobial</td><td align="center" valign="middle" rowspan="1" colspan="1">Gram-positive: <italic>Staphylococcus aureus</italic> ATCC 29737, <italic>Streptococcus pyogenes</italic>, <italic>Bacillus subtilis</italic> ATCC6633, <italic>Streptococcus epidermidis</italic> ATCC 12228, and <italic>Propionibacterium acnes</italic>; Gram-negative: <italic>Escherichia coli</italic> ATCC 10536, <italic>Salmonella typhi</italic>, <italic>Pseudomonas aeruginosa</italic> ATCC 25619, <italic>Klebsiella pneumoniae</italic> ATCC 10031, and <italic>Proteus vulgaris</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B24-molecules-26-02377" ref-type="bibr">24</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gram-positive: <italic>Staphylococcus aureus</italic> (MTCC 96), <italic>Staphylococcus epidermidis</italic> (MTCC 435), and <italic>Streptococcus mutans</italic> (MTCC 890); Gram-negative: <italic>Klebsiella pneumoniae</italic> (MTCC 109), <italic>Pseudomonas aerugenosa</italic> (MTCC 741), <italic>Escherichia coli</italic> (MTCC 723), <italic>Escherichia coli</italic> (DH5&#x1d6fc;), and <italic>Salmonella typhimurium</italic> (MTCC 98)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B22-molecules-26-02377" ref-type="bibr">22</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methanol extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Carrageenin-induced hind-paw edema test in rats; acetic acid-induced vascular permeability and writhing test in mice</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B46-molecules-26-02377" ref-type="bibr">46</xref>]</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Ethanol extract</td><td align="center" valign="middle" rowspan="1" colspan="1">Antioxidant</td><td align="center" valign="middle" rowspan="1" colspan="1">SOD enzyme activity in rat induced by HFD</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B44-molecules-26-02377" ref-type="bibr">44</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Anti-asthma</td><td align="center" valign="middle" rowspan="1" colspan="1">PMA-induced mucin production in NCI-H292 cells</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B47-molecules-26-02377" ref-type="bibr">47</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neuroprotective</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LPS-induced neuronal cell loss and astroglial activation within the hippocampus using adult male Wistar rats</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B19-molecules-26-02377" ref-type="bibr">19</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ether fraction</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Carrageenin-induced hind-paw edema test in rats; acetic acid-induced vascular permeability and writhing test in mice</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B46-molecules-26-02377" ref-type="bibr">46</xref>]</td></tr><tr><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Hexane fraction</td><td rowspan="3" align="center" valign="middle" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" rowspan="1" colspan="1">Carrageenin-induced hind-paw edema test in rats; acetic acid-induced vascular permeability and writhing test in mice</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B46-molecules-26-02377" ref-type="bibr">46</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">TPA-induced ear edema in rats</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B48-molecules-26-02377" ref-type="bibr">48</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">LPS-induced NO production in RAW264.7 cells</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B45-molecules-26-02377" ref-type="bibr">45</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Antioxidant</td><td align="center" valign="middle" rowspan="1" colspan="1">H<sub>2</sub>O<sub>2</sub> scavenging activity; &#x003b1;-glucosidase inhibition</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B43-molecules-26-02377" ref-type="bibr">43</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anticancer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxicity of DNM in MES-SA/DX5 and MCF-7/ADR cell lines</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B27-molecules-26-02377" ref-type="bibr">27</xref>,<xref rid="B28-molecules-26-02377" ref-type="bibr">28</xref>]</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Chloroform fraction</td><td align="center" valign="middle" rowspan="1" colspan="1">Antioxidant</td><td align="center" valign="middle" rowspan="1" colspan="1">DPPH scavenging activity</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B43-molecules-26-02377" ref-type="bibr">43</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Anticancer</td><td align="center" valign="middle" rowspan="1" colspan="1">Cytotoxicity against A549 and SNU-638 cell lines</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B25-molecules-26-02377" ref-type="bibr">25</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxicity of DNM in MES-SA/DX5 and MCF-7/ADR cell lines</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B27-molecules-26-02377" ref-type="bibr">27</xref>,<xref rid="B28-molecules-26-02377" ref-type="bibr">28</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ethyl acetate fraction</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antiaging, skin whitening, and anti-inflammation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DPPH scavenging, HDFa collagen secretion, tyrosinase inhibition, and LPS-induced NO production in RAW264.7 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B17-molecules-26-02377" ref-type="bibr">17</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenylbutenoid-rich fraction</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LPS-induced NO production in RAW264.7 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B45-molecules-26-02377" ref-type="bibr">45</xref>]</td></tr><tr><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<bold>1</bold>
</td><td rowspan="4" align="center" valign="middle" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" rowspan="1" colspan="1">EPP, AA, TPA, or carrageenan-induced ear edema in rats; collagen, ADP, AA, or PAF-induced platelet aggregation</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B42-molecules-26-02377" ref-type="bibr">42</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">LPS-induced PGE2 production in RAW264.7 cells</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B9-molecules-26-02377" ref-type="bibr">9</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">LPS-induced NO production in RAW264.7 cells</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B13-molecules-26-02377" ref-type="bibr">13</xref>,<xref rid="B45-molecules-26-02377" ref-type="bibr">45</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">LPS-induced PGE2 level and COX-2 expression in human dental pulp cells</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B49-molecules-26-02377" ref-type="bibr">49</xref>]</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Anticancer</td><td align="center" valign="middle" rowspan="1" colspan="1">Cytotoxicity against HT-1080 cell line</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B8-molecules-26-02377" ref-type="bibr">8</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cytotoxicity of DNM in MCF-7/ADR cell lines</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B29-molecules-26-02377" ref-type="bibr">29</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Invasion of HT-1080 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B10-molecules-26-02377" ref-type="bibr">10</xref>]</td></tr><tr><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<bold>2</bold>
</td><td rowspan="2" align="center" valign="middle" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" rowspan="1" colspan="1">TPA-induced ear edema in rats</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B48-molecules-26-02377" ref-type="bibr">48</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">LPS-induced NO production in RAW264.7 cells</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B45-molecules-26-02377" ref-type="bibr">45</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" colspan="1">Chondroprotective effect</td><td align="center" valign="middle" rowspan="1" colspan="1">Cytokine-induced cartilage degradation in explant culture</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B50-molecules-26-02377" ref-type="bibr">50</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cytokine-induced up-regulation of catabolic genes involved in joint erosion in SW982 cells</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B51-molecules-26-02377" ref-type="bibr">51</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" colspan="1">Anti-asthma</td><td align="center" valign="middle" rowspan="1" colspan="1">Pro-MMP-9 by house dust mite allergens; MMP-9 expression in PMA-stimulated NCI-H292cells</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B52-molecules-26-02377" ref-type="bibr">52</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Molecular docking and molecular dynamics simulations with 5-LO enzyme</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B53-molecules-26-02377" ref-type="bibr">53</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Melanogenic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Melanin synthesis in B16F10 cells and human primary melanocytes; USF-1-mediated tyrosinase expression; hyperpigmentation in brown guinea pigs.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B21-molecules-26-02377" ref-type="bibr">21</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<bold>3</bold>
</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" rowspan="1" colspan="1">TPA-induced ear edema in rats</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B48-molecules-26-02377" ref-type="bibr">48</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LPS-induced NO production in RAW264.7 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B45-molecules-26-02377" ref-type="bibr">45</xref>]</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<bold>4</bold>
</td><td rowspan="2" align="center" valign="middle" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" rowspan="1" colspan="1">TPA-induced ear edema in rats</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B48-molecules-26-02377" ref-type="bibr">48</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">LPS-induced PGE2 level and COX-2 expression in human dental pulp cells</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B49-molecules-26-02377" ref-type="bibr">49</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Anticancer</td><td align="center" valign="middle" rowspan="1" colspan="1">Antiproliferative activity toward CEMss, HepG2, MCF-7, MDA-MB-231, and human blood mononuclear cell lines; apoptosis in CEMss cells via induction of p53-independent mitochondrial signaling pathway</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B54-molecules-26-02377" ref-type="bibr">54</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neurotrophic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of neurite sprouting in PC12 cells; neurogenesis and neurite growth and protection in primary cultured rat cortical neurons; hippocampal neurogenesis in OBX-induced mice</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B20-molecules-26-02377" ref-type="bibr">20</xref>]</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<bold>5</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" rowspan="1" colspan="1">TPA-induced ear edema in rats</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B48-molecules-26-02377" ref-type="bibr">48</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Chondroprotective effect</td><td align="center" valign="middle" rowspan="1" colspan="1">Cytokine-induced cartilage degradation in explant culture</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B50-molecules-26-02377" ref-type="bibr">50</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Collagen promoting</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HDFa collagen secretion</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B17-molecules-26-02377" ref-type="bibr">17</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<bold>6</bold>
</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" rowspan="1" colspan="1">TPA-induced ear edema in rats</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B48-molecules-26-02377" ref-type="bibr">48</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LPS-induced PGE2 level and COX-2 expression in human dental pulp cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B49-molecules-26-02377" ref-type="bibr">49</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<bold>8</bold>
</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" rowspan="1" colspan="1">Carrageenin-induced hind-paw edema test in rats; acetic acid-induced vascular permeability and writhing test in mice</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B46-molecules-26-02377" ref-type="bibr">46</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Carrageenin-induced hind-paw edema test in rats</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B40-molecules-26-02377" ref-type="bibr">40</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>9</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LPS-induced NO production in mouse peritoneal macrophages</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B13-molecules-26-02377" ref-type="bibr">13</xref>]</td></tr><tr><td rowspan="6" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<bold>11</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" rowspan="1" colspan="1">PGE2 production in the LPS-stimulated mouse macrophage RAW264.7 cells</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B9-molecules-26-02377" ref-type="bibr">9</xref>]</td></tr><tr><td rowspan="4" align="center" valign="middle" colspan="1">Anticancer</td><td align="center" valign="middle" rowspan="1" colspan="1">Cytotoxicity against A549, Col2, SNU-638, and HT-1080 cell lines</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B8-molecules-26-02377" ref-type="bibr">8</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Growth inhibition and induction of G1 phase cell cycle arrest in A549 cells</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B26-molecules-26-02377" ref-type="bibr">26</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cytotoxicity of DNM in MCF-7/ADR cell line</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B29-molecules-26-02377" ref-type="bibr">29</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Activation of NDPK activity of recombinant human Nm23-H1 and cellular NDPKs in MDA-MB-231 cells; in vitro invasion and migration of MDA-MB-231 cells; in vivo metastasis in MDA-MB-231-Luc-D3H2LN mice</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B32-molecules-26-02377" ref-type="bibr">32</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neurotrophic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of neurite sprouting in PC12 cells; neurogenesis and neurite growth and protection in primary cultured rat cortical neurons; hippocampal neurogenesis in OBX-induced mice</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B20-molecules-26-02377" ref-type="bibr">20</xref>]</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<bold>14</bold>
</td><td rowspan="2" align="center" valign="middle" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" rowspan="1" colspan="1">PGE2 production in the LPS-stimulated mouse macrophage RAW264.7 cells</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B9-molecules-26-02377" ref-type="bibr">9</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">LPS-induced NO production in mouse peritoneal macrophages</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B13-molecules-26-02377" ref-type="bibr">13</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Anticancer</td><td align="center" valign="middle" rowspan="1" colspan="1">Cytotoxicity of DNM in MCF-7/ADR cell lines</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B29-molecules-26-02377" ref-type="bibr">29</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Invasion of HT-1080 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B10-molecules-26-02377" ref-type="bibr">10</xref>]</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<bold>17</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" rowspan="1" colspan="1">Carrageenin-induced paw edema in rats; Carrageenin-induced rat pleurisy; adjuvant-induced arthritis</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B7-molecules-26-02377" ref-type="bibr">7</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Analgesic</td><td align="center" valign="middle" rowspan="1" colspan="1">Acetic acid-induced writhing response in mice; tail-flick test in rats</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antipyretic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yeast-induced hyperthermia in rats</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<bold>18</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" rowspan="1" colspan="1">PGE2 production in the LPS-stimulated mouse macrophage RAW264.7 cells</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B9-molecules-26-02377" ref-type="bibr">9</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anticancer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxicity against A549, Col2, SNU-638, and HT-1080 cell lines</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B8-molecules-26-02377" ref-type="bibr">8</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>21</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anticancer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxicity of DNM in MCF-7/ADR cell lines</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B30-molecules-26-02377" ref-type="bibr">30</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>22</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anticancer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cellular accumulation and efflux of DNM in MCF-7/ADR cell lines; in vivo application of paclitaxel and co-administration using male Sprague Dawley rats</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B30-molecules-26-02377" ref-type="bibr">30</xref>,<xref rid="B31-molecules-26-02377" ref-type="bibr">31</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<bold>25, 27, 55</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" rowspan="1" colspan="1">LPS-induced NO production in mouse peritoneal macrophages</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B13-molecules-26-02377" ref-type="bibr">13</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anticancer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Invasion of HT-1080 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B10-molecules-26-02377" ref-type="bibr">10</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>30, 42</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LPS-induced NO production in mouse peritoneal macrophages</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B13-molecules-26-02377" ref-type="bibr">13</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>43, 44</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antioxidant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thymocytes under H2O2-iduced oxidative stress</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B42-molecules-26-02377" ref-type="bibr">42</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<bold>46</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Collagen promoting</td><td align="center" valign="middle" rowspan="1" colspan="1">HDFa collagen secretion</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B17-molecules-26-02377" ref-type="bibr">17</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Skin whitening</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tyrosinase inhibition</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B17-molecules-26-02377" ref-type="bibr">17</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>47</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LPS-induced NO production in Rwa264.7 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B17-molecules-26-02377" ref-type="bibr">17</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>48</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neurotrophic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neurite outgrowth of NGF-mediated PC12 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B14-molecules-26-02377" ref-type="bibr">14</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<bold>49</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" rowspan="1" colspan="1">LPS-induced NO production in mouse peritoneal macrophages</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B13-molecules-26-02377" ref-type="bibr">13</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neurotrophic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neurite outgrowth of NGF-mediated PC12 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B14-molecules-26-02377" ref-type="bibr">14</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>59, 60</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Carrageenin-induced hind-paw edema test in rats</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B40-molecules-26-02377" ref-type="bibr">40</xref>]</td></tr></tbody></table></table-wrap></floats-group></article>